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INTRODUCTION 
 The Siddha system is a unique one. It is medicines were bestowed by the 
great Siddhars, after attaining spiritual knowledge through physical perfection and 
spiritual salvation. 
 This system is passed from lord Siva to his consort and then to Nandhi, 
who in turn taught to Dhanvantri, who in turn to Aswini Devas, the twins and they 
narrated these works to Agathiar. Agathiar in turn told to saint Theriyar and finally 
Theraiyar narrated these to rishi Devar. 
Siddhars have made a through study on the utility of Herbs, Metals, 
Minerals, etc. substances and formulated the medical preparations consists of 
 1.Metals, 2.Inorganic secondary minerals (Uparasams), 3.Organic 
salts,4.Paadanams and there by attained prominence in the field of Medicine. 
Siddhars have followed various methods for their medicinal preparations. Some of 
them are, 
 Process involving drugs based on combined ratio of five elements ( Aega 
mooligai prayogam)  
(1) Process of Antagonism and Synergism(Maarana Prayogam) 
(2) Process involving Acids  (Thiravaga Pirayogam) 
(3) Process involving Alkaline (Seyaneer Pirayogam) 
(4) Process involving Muppu (Muppu-chuuna Pirayaogam) 
Siddhars had not only discovered the medicines for curing the diseases but 
also sought the ways and means for eternal life by self-attaiment.In other words, 
they the searched various ways and means to protect the human body from ageing. 
In siddha system, diagnosis is made from eight tools, namely, 
1. Physical signs and symptoms 
2. Colours 
3. Speech 
4. Eyes 
5. Tongue 
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6. faeces 
7. Urine 
8. Naadi ( Pulse ) 
 Balavagadam (or) Kuzhanthai maruthuvam is that Branch of Medical 
science of siddhars, which deals with the diseases of the children, their essential 
nature, especially on the functional changes together with planetary influence, 
marbid diathesis etc., and the treatment. 
 The classification of diseases from birth to childhood, according to 
paruvangal and description of various lines of treatment with specific herbs, is a 
distinct feature of pediatric medicine in Siddha. 
 In the early infancy i.e. up to three months, only leafy extract is 
administered internally to baby either by applying the medicine to mother’s breast, 
facilitating the baby to suckle the medicine along with the milk.  Pasty medicines 
applied over the anterior Fontanel of the baby to produce quick relief to baby by 
cutaneous absorption.  Similarly medicine herbs for bath also help in quick 
recovery. 
 From the first year of the life of the baby, due to exposure to external 
pollution and contact, the child develops systemic diseases with vague signs and 
symptoms without clear-cut etiology.  In later childhood diseases manifest as 
chronic respiratory and gastro intestinal disorders, nutritional deficiencies, liver 
and spleen disorders, skin infections, metabolic and neurological diseases. Though 
many lines of treatment are described for each disease, no specific treatment is 
followed for each disease. 
 Childcare being different in many aspects from adult care it is considered a 
separate branch of medicine. 
 A disease “Kanam” which affects a large percentage of children in India.  
The disease causes wasting, fever, makes the child irritable, loss of appetite, In the 
child affects the growth of the child.  
 Let us try to spread the knowledge of siddha medicine and do well for the 
public
AIM AND OBJECTIVE 
 
   “Kanam” is one of the most common illness in children. It is one of the 
major problem  in most of the developing countries like India. Kanam is closely 
related to cultural, food habits, and socio-economic status. 
 Poor nutrition, poor health care facilities poor hygienic are common causes 
of this disease  
 Kanam is mostly followed by untreated mantham disease. If it is not treated 
properly.  It may cause fatal to the children 
OBJECTIVES: 
1. To identify the “kanam” and its actual characters of the disease as per 
the Siddha view (Balavagadam text) 
2. To explore definition, etiology, clinical features, diagnosis, 
investigations, treatment of kanam as laid down from their Siddha 
literature. 
3. To make the correlative study of the Siddha and modern aspects of this 
disease. 
4. To evaluate clinical trial of the action of “Madhulai Nei” Internally for 
Kanam. In this preparation, Seenthil sarkarai have good immune - 
modulator effects on kaba disease. Madhulai Juice has mainly indicated 
for kaba diseases in moologai gunapadam text. 
5. To evaluate the Bio-chemical and pharamacological analysis of the 
drug. 
6. To evaluate the efficacy of the trial medicine on Antimicrobial activity 
by invitro studies. 
7. To re establish the treatment for kanam with the “Madhulai Nei”. 
8. Finally, to create awareness among the public about Siddha treatment 
for kanam. 
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REVIEW OF LITERATURES 
A. SIDDHA ASPECT 
g{l<!
! ! “giqLgecjb!uip<k<kqg<!glzuiseqjbh<!Ohix<xq!
! ! niqb!osf<klqpqeiOz!bgk<kqb!Leque<!osie<e!
! ! ohiqb!li!uqbikqbie!OhSlg<gj{bqe<!Oxi]l<!
! ! okiqbOu!Huqbqe<lQK!osh<Hue<!sqf<jkjuk<Ok”!
! ! ! ! ! .!hvvisOsgvl<!;!hizOvig!fqkiel<!
! ! ! ! ! ! ! ! ! )himz<!379*!
! ! sqf<jkuqm<!mgzi!Lg<gm<!Omuje!u{r<gqh<!hizi<!
! ! uf<kOui!vi{<ce<!Olzib<!uVk<kqMr<!gj{bqe<!Oxi]l<!
! ! kf<kqM!fvl<h!okz<zif<!kir<gqOb!b,jeh<!hx<xq!
! ! df<kqM!lqvk<k!olz<zi!lLoke!U{<[!le<Ox/!
! ! ! ! ! ! ! ! ! )himz<!37:*!
2/!!Ofib<!-bz<!)Definition) 
 “g{l<”! we<hK! “gIh<hs<! S,M”! weg<! %XuI/! ! kib<! gVUx<xqVg<Gr<!
gizk<kqz<! ng! Hxg<! giv{r<gtqeiz<! dmzqz<! kr<gqbqVg<Gl<! &zs<! S,M!
OlZg<G!gqtl<hq!Nlisbk<jkBl<,!gIh<hisbk<jkBl<!kig<Gl</!!!
! OlZl<! -0K! Gpf<jkgTg<G! d{<miGl<! lif<k! Ofib<! LPuKl<!
G{ljmbilz<! dmzqz<! -Vf<K! Lx<xq! lif<kk<kqe<! okimI! Ofib<! Ng!
d{<migqxK/!
!  
II/!Ofib<!Okie<Xl<!ubK!)Age) 
! “g{l<”! –! Gpf<jkgt<! hiZl<! Gck<K! OsiX! d{<[l<! hVuk<kqz<!
uVl<!OfibiGl</!
! -0K! Gpf<jkbqe<! &e<xili{<M!Lkz<! Wpili{<M! ujv! uVl<Ofib<!
we<hjk, 
! “we<eOu!g{!&e<X!uVmf<!okim<Om!
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! Wpi{<M!lm<Mg<G!lqVg<Gr<!gizl<”!
we<El<!osb<Bt<!uiqgtiz<!nxqbzil</!
! OlZl<! hvvis! Osgvl<! wEl<! F~zqe<hc,! nke<! hizOvig! fqkie!
hmzk<kqz<! g{l<! Gpf<jkgtqe<! 23! ubK! ujvbqZl<! gi[l<! Ofib<! we<X!
-bl<HgqxK/!n0kiuK, 
! “we<x!OkiI!gj{!gmiLlqh<hc!obPf<K!ohir<gq!
! fqe<x!OhI!hkqoem<M!kieqjxf<kqV!li{<ce<!Olzib<g<!
! ge<xqb!hizI!olb<bqx<!h{<{qv{<mi{<M!giXl<!
fqe<xqM! ole<X! Le<ei{qgp<k<kqje! Lequee<Ox!”! we<X!
%xh<hm<Mt<tK/!
-jkOb!hizuigmLl<!
“lzLR<!szL!lqgk<!kQb<f<K!liIhqzkqg!Svr<giBl<!
lzLl<!ubqX!lqg!ouiqBl<!utlib<!kjzB!lqg!lbg<Gl<!
szLl<!uvt<!kQ!kie<!GjxBl<!s{<mitl<!OhiZm<!Svlil<!
“kzOl”!he<eqv{<mi{<M!lm<Ml<!kekib<!uVdr<!G{lqKOu”!
we<Xl<!%XgqxK!
! weOu!g{lieK!Gpf<jkgtqz<! hqxf<kK!Lkz<! 23!N{<M!lm<cZl<!
Okie<Xl<!Ofib<!weUl<!ogit<tzil</!
!
III/!!Ofib<!uVl<!upq!(Aetiology) 
1. dt<tl<! oktqux<X! -Vg<Gl<! kibqeK! dmz<! fqjz!
hikqg<gh<hMgqxK/! ! weOu!nk<kijb!n{<cuiPl<! Gpf<jkbqe<!
dmz<!fqjzBl<!hikqg<gh<hMgqxK/!
2. nkqglie! d]<{l<! Wx<hMl<! OhiK! sqOzk<Kll<! nkqgligs<!
OsIukiZl<! kib<g<G! nkqglig! Kbvl<! uf<K! njmgqxK/!!
nf<Ofvr<gtqz<! hx<hz! fQIgjt! nk<kib<! nVf<KukqeiZl,<!
ncg<gc!szOkiml<!Wx<hMukqeiZl<!OlZl</!
3. OlZl<,! hikqg<gh<hm<cVg<Gl<! kib<! hsqBmeqVg<Gl<! OhiK!
nk<kibqe<! hijz! Gpf<jk! hVGukqeiZl<! Gpf<jk! gTg<G!
g{!Ofib<!uVgqxK/!
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-g<gVk<jk!nObik<kqkisI!hizuigml<!gQp<!uVliX!%XgqxK/!
! ! “JbK!%cx<oxe<xiz<!niqjubI!Kbvf<ke<eiz<!
! ! osb<b!hx<!HezVf<kq!osxq!sz!Okimf<!ke<eiz<!
! ! jhbv!uz<GziTl<!hsqBmeqVf<kkiZl<!
! ! Kb<b!OkiI!Gpuq!gm<G!g{r<gTf<!Okie<X!le<Ox!” 
g{l<! uVl<! upqjb! kqVut<Tu! fibeiI! -bx<xqb! fuvk<kqe!
juk<kqb!sqf<kil{q-911z<!gUel{q.211z<!%xqbuiX;!
! -kqz<,! kf<jkbqe<! Oum<jgbiz<! hq{<ml<! gezqz<! nchm<M! g{l<!
uVukig!%xh<hm<t<tK!n0kiuK,!
! ! “hivie!ogx<houm<jm!lQVl<!hg<Guk<kqz<!
! ! Ouvie!uqf<K!outqh<hm<M!Obieq!uqPf<k!okexix<!
! ! givie!hq{<mr<!gezqzc!hm<Mg<!gif<kqbqeix<!
! ! %vib<!g{Sv!olb<K!ole<Oxbie!%xqOeOl”!
we<X!g{l<!Okie<Xl<!upq!%xh<hm<Mt<tK/!
ke<uf<kqiq!juk<bl<!wEl<!F~zqz<!g{l<!Okie<xq!uqkl<!%Xkz<!
! -f<F~zqz<! g{lieK! Le<! o\e<lr<gtqz<! osb<k! kQuqjegt<!
kf<jkbigUl<,! -h<hqxh<hqz<! osb<Bl<! kQuqjegjt! kibigUl<! njmf<K!
“]bg<!Glive<”!hqxg<gqxie<!we<X!%XgqxK/!
!
! ! “sQiqb!okie<jl!osb<k!kQuqje!kf<jkbigh<!
! ! hiiqzqh<!hqxh<hqx<!osb<k!hiuOl!kibkigh<!
! ! Ohiqbs<!sbg<!Glive<!uqxf<kqzi!gqx!lk<kh<Oh!
! ! giiqb!osuqzqk<!kibib<!“g{l<”!ohx!utVl<!fitqz<!
we<X!g{l<!Okie<Xl<!uqkl<!%xh<hm<Mt<tK/!
!
!
!
!
!
!
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2/!!Ofib<!w{<;!
2 Ofibqe<!ujggt<;!
2/ nObik<kqkisI!hiz!uigml<!;!35!ujgbigUl<!
3/ Nuqbtqg<Gl<! nLkLjxSVg<gl<! ;! 34! ujg! lx<Xl<! 29!
ujgbigUl<!hqiqk<K!%XgqxK/!
4/ hvvisOsgvl<!wEl<!F~z<!29!ujgbie!g{r<gjtBl<,!
5/ ke<uf<kqiq!juk<kqb!F~z<9!ujg!we!ujgh<hMk<kqBt<teI/!
!
#okijgbie! g{r<gt<! wz<zil<! gIh<hs<! S,M#! –! weg<! %xqb!
nObik<kqkisI! hizuigml<! .! g{k<kqe<! ujggtig! 35! we<X!
ujgh<hMk<kqBt<tiI/!!njugjt!gQp<uVliX!%XOuil</!
!
2/! utq!g{l<! 24/! uQg<gg<!g{l<!
3/! npx<!g{l<! 25/! hqxg<!g{l<!
4/! Jb!g{l<! 26/! nf<kg!g{l<!
5/! lif<k!g{l<! 27/! lf<kiv!g{l<!
6/! fQIg<!g{l<! 28/! wiq!g{l<!
7/! hqvtq!g{l<! 29/! fQvil!g{l<!
8/! S,zq!g{l<! 2:/! -vk<k!g{l<!
9/! Spq!g{l<! 31/! Lg<G!g{l<!
:/! lgi!g{l<! 32/! &z!g{l<!
21/! DK!g{l<! 33/! Ohvil!g{l<!
22/! uvt<!g{l<! 34/! vk<k!g{l<!
23/! ogikqh<H!g{l<! 35/! sqr<gq!lif<k!g{l<!
!
-r<rel<! g{l<! 35! ujggtig! hqiqk<kxqbh<hcEl<,! hx<hz! sqk<k!
lVk<Ku! F~x<gtqz<! g{k<jk! -keqe<Xl<! OuXhMk<kq! sqz! ujggt<!
%xh<hm<Mt<te/!Njugjt!gQOp!gi{<Ohil</!
!
!
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!
N/!Nuqbtqg<Gl<!nLk!Ljxs<!SVg<gl<!
! Nuqbtqg<Gl<! nLk! Ljxs<! SVg<gl<! .! F~zqe<hc! hizuigm!
hmzk<kqz<!-ke<!okijggtig!34!we<X!%xh<hm<Mt<tK/!!njubiue/!
!
2/! uikg{l<! 24/! uQg<g!g{l<!
3/! hqk<k!g{l<! 25/! hqxg<!g{l<!
4/! sqOzk<Kl!g{l<! 26/! Nlg<!g{l<!
5/! lif<k!g{l<! 27/! uxm<sq!g{l<!
6/! fQIg<!g{l<! 28/! Lg<G!g{l<!
7/! hqvtq!g{l<! 29/! OhiIg<!g{l<!
8/! S,jzg<!g{l<! 2:/! -vk<k!g{l<!
9/! Spq!g{l<! 31/! Fs<S!lif<k!g{l<!
:/! lgi!g{l<! 32/! DK!lif<k!g{l<!
21/! DK!g{l<! 33/! lif<k!g{l<!
22/! uxm<sq!g{l<! 34/! wiq!g{l<!
23/! ogikqh<H!g{l<! ! !
!
! Olx<gi[l<! 34! NgUl<! -Ok! F~zqz<! g{r<gt<! 29! we<Xl<!
%xh<hm<Mt<tK/!!n/0kiuK!biokeqe<, 
 
 “hivh<hi!g{!uGh<H!hkqoem<miGl<!
! hiceiI!uik!g{l<!hqk<k!g{Ll<!
! Ofvh<hi!Osk<l!g{l<!fQIg<!g{lil<!
! hqvtq!g{l<!S,jzg<!g{f<!kie!
! sivh<hi!DK!g{l<!Spq!g{f<kie<!
! %vh<hi!ogikqh<H!g{l<!hqx!g{f<kie<!
! Gxqh<hie!Np!g{l<!uQg<g!g{f<kiOe!” 
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 “kieie!Okjv!g{l<!Lg<G!g{f<kie<!
! keqbie!&z!g{l<!OhiI!g{f<kie<!
! Deie!vk<k!g{l<!uqmi!lif<k!g{Ll<!
! DK!lif<kg<!g{lil<!lif<k!g{f<kiEl<!
! Ogieie!lf<kiv!g{Lf<!kiEl<!
! %vie!wiqg{li!lqVhk<K!&e<Xl<!
! hieie!g{r<gt<!he<eqv{<M!lm<Ml<!
! hizgIg<G!OfVole<X!hgIf<kkiOl!” 
 -s<osb<Btqz<! g{r<gt<! hkqoem<M! we<X! Lkz<! himzqz<! %xq!
-v{<mil<!himzqz<!-Vhk<K!!&e<X!we<X!%xh<hMgqxK/!
! keqbig! g{l<! we<x! hiGhim<cz<! dt<tju! 29! we<Xl<! OuX!
Ofib<gzh<H!ogi{<m!g{l<!6!Ng!olik<kl<!34!we<X!nxqbg<!gqmg<gqxK/!
!
-/!!hvvis!Osgvl<;!
! hvvis!Osgvl<!wEl<!F~x<hc!hizOvig!fqkiel<!g{k<kqe<!okijg!29!
lm<Ml<!we<X!uqiqk<Kg<!%XgqxK/!!nke<hc!nxqukiuK/!
! “dvolEr<!gj{g{<!Le<OeVjvk<kiuXjvh<hg<!Og{<lqe<!
! SvolEr<!gj{Bolie<X!K~r<Glg<!gj{Bolie<X!
! fqvuqb!&z!lqvk<k!fQr<gVl<!uxm<sq!ouh<Hg<!
! gVUX!leze<!uQr<gq!%cbOkiI!lR<s!{Qze<!
! fQzlir<!gj{bqOeM!fqe<xqM!ouTh<H!liGl<!
! sizOu!sk<kq!OlZf<!kh<hqzi!lif<k!Olgl<!
! Olzkil<!uqjegt<!Ohiz!lqGf<kqMr<!gpqs<sz<!gisl<!
! NzliiqVl!oub<h<H!liuqju!hkqoem<miOl!” 
! we<X!29!Ng!g{k<kqe<!ujggt<!uqtg<gh<hm<Mt<tjk!gi{<gqOxil</!
!
!
!
!
!
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=/!!ke<uf<kqiq!juk<kqb!F~z<!
! ke<uf<kqiq! juk<kqb! F~zqz<! sbOvig! fqkiek<kqe<! hc! -jk! 9!
ujggtig!hqiqk<K!nxqbh<hMgqxK/!!Njubiue;!
!
2/! uiz!sbl<! 6/! khe!sbl<!
3/! uQv!sbl<! 7/! sbl<!
4/! kV{!sbl<! 8/! NIkl<!
5/! g{qg!sbl<!! 9/! zm<sll<!
 
TV sil<hsqul<!hqt<jt!ngvikqbqe<hc!!
!
 g{lieK, liki! hqkig<gtqe<! fik! uqf<KGt<tmr<gqb! uikikq!
Oki]r<gtqeqe<X! dx<hk<kqbigqg<! gVh<hisbk<Ks<! sqSjuh<! hx<xq!
ns<sqSuqeK! wPujgk<! kiKg<gTl<! ue<jlbjmBr<! gizk<K! njk!
Ofibiz<!uVf<ks<!osb<Bl<!Ofib</!
!
-K!klqp<!juk<kqbh<! hc! Ofibqe<!G{l<!Gxq!-jugtqe<! ohbiqm<M!
nOeg!uqklib<g<!ogit<th<hMl</!
!
A congenital disease of the child arising from the maturity of the bad 
humours inherited from the parents. It is an atrophy resulting from the 
enlargement of the bowls (tabes mesenterica). The disease progresses in 
several forms as the child advances in age.!
!
According to Tamil medical science it consists of different kinds and their 
names signify the symptoms characterising the disease as shown under:!
2/!lif<k!g{l<, Atropy resulting from indigestion. 
! 3/!Lg<Gg<!g{l<, Atropy marked by prolapse of the anus due to   
   straining. 
! 4/!DK!g{l<, Atropy attended with a diffuse turgidity arising from  
    the collection of morbid fluid.!!
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! 5/!Spqg<!g{l<, Atropy followed by the whirling of the eyes. 
! 6/!$jzg<!g{l<, Atropy characterisedby acute pain on the sides. 
! 7/!Nlg<!g{l<, Atropy arising from nutritional disorders and marked  
            by mucous in the stools. 
! 8/!&zg<!g{l<, Atropy associated with the heat of the lower rectum 
9/!$m<Mg<!g{l<!nz<zK!gpqg<g{l<, Atropy due to excess of heat       in   
the system resulting diarrhoea. 
! :/!uikg<!g{l<, Atropy caused by the three morbid humours of the   
           system!!!!!!
! 21/!hqk<kg<!g{l<!!!!!!
! 22/!sqOzm<Mlg<!g{l<!
! 23/!fQi<g<!g{l<, Atropy marked by the swelling of the extremities due  
           to the collection of morbid fluid. 
! 24/!hqvtqg<!g{l<, Atropy attended with convulsion or fits and rolling  
    of the head 
! 25/!uvm<!g{l<. 
! 26/!ogikqh<Hg<<!g{l<, Atropy following by inflammation of the   
    alimentary tract. 
! 27/!hqvtqg<!g{l<, Atropy arising from congenital causes. 
! 28/<!lgi!g{l<, Atropy associated with aphthae and anemia. 
!!29/!uQg<gg<!g{l<, Atropy distingnished by diffuse swelling of the   
      body. 
! 2:/!Ohii<g<!g{l<, Atropy attended with palpation of the heart and   
   giddiness. 
! 31/!-vk<kg<!g{l<, Atropy followed by haemorrhage internal or   
      external. 
! 32/!wiq!g{l<, Atropy characterized by burning sensation all over the  
        body and sleeplessness. 
! 33/!lf<kivg<!g{l<, Atropy peculiar to rainy season 
 12
! 34/!nf<kgg<!g{l<, Atropy attended with cerebral affections ending  
        in death. 
! 35/!DK!lifkg<!g{l<, Atropy attended with indigestion and   
    swelling of the abdomen. 
! 36/!uq]!lif<kg<!g{l<, Atropy or another variety of mantha kanam 
! 37/!Okjvg<!g{l<, Atropy associated with internal fever and marked  
      by great emaciation. 
 
   These symptoms according to the western science, are said to be caused 
by faulty nutrition,bad or improper feeding or from an undeveloped conditions 
of the constitutional disease in children such as rickets, worm in the 
intestines,tabes mesentrica, scrofula, bright’s disease, malarial influences, 
infantial remittent fever etc, invariably attended with atropy. 
 
II. g{k<kqe<!ohiK!Gxq!G{r<gt<;!
2/ Gpf<jkg<G! lif<kOfib<! hzLjx! uf<K! nK! Lx<xqZl<!
G{ljmbilz<! dml<hqe<! dt<hGkqbqOzOb! -Vf<K! Lx<xq!
-Vh<hkiz<!d{<miGl</!
3/ -g<g{k<kqe<!Lg<gqb!Gxqgtiue;!
n/ ubqX!Ofikz<!
N/ fi!Oug<gimikz<!
-/! Olz<!&s<S!d{<mikz<!
=/! gI!gI!wEl<!yzqBme<!-Vlz<!d{<mikz<!
d/ osiz<z! Lcbikhc! hzuqklie! OuXhiM! dml<hqz<!
Wx<hMkz<!
D/ ohiXk<K,!ohiXk<K!Svl<!gib<kz<!
OlZl<!g{<gtqe<!fqxl<!-bx<jg!fqxk<kqeqe<Xl<!lixqg<!gi{h<hMkz<!
!
!
!
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 g{<!ouV{<M!hiIk<kz<!
 ds<sqbqz<!Gpq!uqPkz<!
 oki{<jm!gl<lzig!OhSkz<!
 Lgk<kqz<!sqxqK!uqbIju!d{<mikz</!
 ubqX!gpqkz<,!gib<kz</!
Ngqb!-jubiUl<!g{k<kqe<!ohiKg<Gxq!G{r<gtiGl</!
!
! -Okime<xqBl<! npz<! nkqgligq! uiBju! hx<xq! nPk<kqg<! ogit<Tl</!
nkeiz<! npz<! k{qukx<G! upqbqz<zilz<! Gpf<jkg<G! nkqgligs<! S,M!
d{<migq!dmz<!g{g{h<H!Wx<hMl</!
!
! Gpf<jk! kijb! uqmilz<! hqck<Kg<ogit<Tl</! ! uib<! dzIf<K! fQI!
Oum<jg! nkqglibqVg<Gl</! ! OhkqbiGl</! ! lzl<! w{<o{b<! gsqUt<tkig!
-Vg<Gl</!
! nk<Kme<!lz!uibqzqVf<K!D{<!gPuqe!fQiqe<!fqxk<jk!Ohie<X!fQI!
gsqf<K!ogi{<Om!-Vg<Gl</!
! sqz!Gpf<jkgTg<G!out<jt!fqxk<Kme<!k{<{QI!OuX,!lzl<!Ouxig!
gpqBl</!
! sqz! Gpf<jkgm<G! De<! gPuqe! k{<{QI! Ohiz! OhkqbiGl<! ubqX!
dh<Hl</! ! jg! giz<gt<! Lgl<! -ju! gXk<Kl<! sqz! slbr<gtqz<! wiqf<Kl<!
GtqIf<Kl<!ouKouKh<H{<miGl</!!-Vlz<!d{<miGl</!
 g{k<kqz<!nez<!uQSuK!Ohie<X!dm<Svl<!-Vg<Gl</!
 g{!Svk<kqz<!lzl<!dt<Ot!kr<gq!uqMl<!
 liIH!%l<H!Ohiz!wPl<hq!uib<!lqgUl<!fix<xolMg<Gl</!
 lzl<!oum<jmbiGl</!!kQb<f<Kl<!-Vg<Gl</!
 fQI!SVr<gq!-Vg<Gl</!
 liIhqz<,!nkqg!Svl<!-Vg<Gl<!
 ubqXl<!lzk<KuivLl<!lqgUl<!wiqBl<!
 lbg<gL{<migq!fi!uxTl</!
 hsqk<kQ!GjxBl,<!dm<Svl<!-Vg<Gl</!
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-u<uiX! -g<Gxq! G{r<gt<! biUl<! Gpf<jkbqe<! 23! ubK! ujvbqz<!
okimIf<K!uVl<!nObik<kq!kisI!hizuigml<!-bl<HgqxK/!
!
III/!g{l<!yu<ouie<xqe<!keq!keq!GxqG{r<gt<;!
I/!utqg{l<;!
! “uik!g{k<kqe<!g{k<kqbz<h!uGh<Ohil<!dmz<!hivlkib<h<!
! Ohik!-jvg<Gl<!fiuvTl<!Hjgf<Ok!-VLl<!kigLme<!
! uik!g{k<kqe<!G{k<kqbz<jh!uGh<Ohil<!dmZl<!hivlkib<h<!
! Ohk!lig!fQIs<!SVg<gil<!hqk<k!g{k<kqe<!G{r<OgOt”!
nkiuK!-kqz<, 
! 2/!!! ubqX!-jvBl<! ! ! !
3/!!! fi!uvTl<!
4/ Hjgs<sZl<,!-VlZl<!d{<miGl<!
5/ nkqg!kigl<!Wx<hMl<!
6/ dmz<!LPuKl<!Svl<!-Vg<Gl<!
7/ hsqB{<migiK/!
3/ hqk<k!g{l<!
! “OgOt!hqk<k!g{k<kqbz<jh!ogicbi!BmZl<!wiqs<sZ{<mil<!
! fiOt!dzIk<kq!liI!hqcg<Gl<!fig<Gr<!gjmuib<!H{<{iGl<!
! hiOt!SvLl<!gib<f<okiiqg<Gl<!hVgg<!gpqB!lR<sje!Ohiz<!
! kiOe!lbg<Gl<!kjz!gqXg<Gl<!six<XR<!Osm<h!G{r<gOt!” 
-kqz<, 
2/ dmz<!kgkgoue!wiqBl</!
3/ fitig!dmz<!dzVl</!
4/ liIH!hqcg<Gl</!
5/ fig<G,!gjmuibqz<!H{<!d{<miGl</!
6/ Svl<!-Vg<Gl</!
7/ lR<st<!fqxlib<!ubqX!gpqBl<!
8/ lbg<gl<,!kjz!gqX!gqXh<H!-ju!-Vg<Gl<!
-jubiUl<!hqk<k!g{k<kqe<!-bz<hil</!
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!
4/!!Osk<Kl!g{l<;!
! “G{liR<!Osm<h!g{k<kqbz<jh!%xg<!Ogtib<!dmzolzil<!
! d{uib<!kqeU!olMk<K!osixq!Dxqg<!gvr<giz<!uQg<glkil<!
! l{uib<!fiXl<!ouh<HmOe!liIhqx<!Ogijp!-VlZme<!
! n{Ol!ouck<K!H{<{iGl<!Nxik<!kue!lqGf<kqMOl!” 
-kqz<!
2/ dmz<!LPuKl<!kqeUl<!osiiqBl<!d{<miGl</!
3/ nK!dml<hqz<!Dxqe!jg,!giz<gtqz<!uQg<gl<!d{<miGl</!
4/ uib<!fix<xl<!Wx<hMl</!
5/ Svk<Kme<!liIhqz<!stq!gm<Ml</!
6/ nkeiz<!-Vlz<!d{<miGl<!
7/ Olz<!uib<!ouck<K!H{<[{<miGl</!
!
!
5/!!lif<k!g{l<;!
! “!g{l<!uV!lif<kk<kiOz!gikze<!g{k<jk!Ogtib<!
! K{l<!wm<M!fijt!ke<eqz<!Kzr<gqMR<!sk<kq!gi[l<!
! h{!ubqxqjvs<!szigqh<!hisq!Ohiz<!OhkqbiGl<!
! uq{!upq!Spe<X!OsiIf<K!uqm!uqmoue<XzVl<!fiOt!” 
 
 “fiukqz<!szlqviK!fjm!Lkz<!nskq!gi[l<!
! giuK!we<X!hize<!gkxqMl<!wMg<Gl<!kigl<!
! %uK!we<X!fiZ!fitK!OgimliGl<!
! kiuK!g{!lif<kf<!kie<!kibqeiz<!n[Gl<!uiOx!” 
!
-kqz<!
2 n0kiuK!lif<k!g{lieK/!kib<!kjzg<G!w{<o{b<!Okb<k<K!
Gtqk<K!d{U!d{<mhqe<!lbg<gl<,!Ogihl<,!kigl<!Lkzqbju!
gtiz<! hMk<K! dxr<gquqm<miz<! nke<! giv{lig! Olz<!
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Ofig<Gr<giz<!outqh<hm<M!uqvg!kihl<!d{<migq!N[me<!%cz<!
nh<OhiK!kr<gq!hqxg<Gl<!Gpuqg<G!-f<Ofib<!d{<migqxK/!
3 -keiz<!lif<k!Ofibiz<!g{l<!hx<xq!Gpf<jk!nf<Ofib<!g{<m!9!!!!
fijtg<Gt<!uif<kq!h{<[l</!
4 ubqX!-jvs<sZme<!hs<jsbigg<!gpqBl</!
5 uqpq!Spe<X!fig<G!dzVl</!
6 fmh<hkqz<!nskq,!nPkz<,!nkqg!kigk<kiz<!uVf<Kkz</!
7 -jubjek<Kl<!Lkz<!5!fim<gt<!nkqglig!-Vg<Gl<!we!lif<k!
g{k<kqe<!Gxq!G{r<gtig!wMk<Kjvg<gh<hm<Mt<tK/!
!
6/!!fQIg<g{l<!;!
! “!fQIg<!g{g<!G{Ol!Ogtib<!fQIOum<jg!Bmzqze<xq!
! OuIg<Gr<jg!gizgmlqz<!ouKh<HXr<!g{<gmiPl<!
! fig<G!uib<!uv{<M!H{<{iGl<!fi!ouch<HX!fQI!Ohkq!
! hiIg<gqOzi!fQI!g{k<kqe<!hx<hz!G{r<gt<!kiOl” 
 
 LgLl<!Hxr<giz<!Hxr<jgBl<!Olikq!lqElqEh<H{<miGl<!
! gjg!OsI!lbg<!gLmz<!OsiIU!k{qbi!ubqx<X!OfiB{<mil<!
! lqgOu!Osigl<!ouTh<H{<miGl<!uqm<M!uqm<M!Svl<!giBl<!
! lgOl!ovik<k!lek<kiOt!uV!fQI!g{k<kqe<!ujgbiOl!” 
-kqz<!
2/ nkqg!fQI!Oum<jg/!
3/ jg!giz<gtqz<!nkqg!uqbIju!Wx<hMkz<!
4/ g{<!hiIju!Gjxkz<!
5/ fi!uib<!-jugtqz<!fQI!ux{<M!H{<{ikz</!
6/ fi!ouch<H!
7/ Lgl<!Hxr<giz<!Hxr<jg!-jugtqz<!lqElqEh<H!d{<mikz<!
8/ fQr<gik!ubqx<X!Ofib</!
9/ Lkzqz<!sqX!S,M!d{<migq!hqe<!Svl<!uqm<M!uqm<M!giBl<!
-jubiUl<!fQI!g{k<kqe<!-bz<hgtiGl</!
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7/!!hqvtqg<!g{l<!
! “!lqGf<k!hqvtqg<!g{k<kqbz<jh!uqiqg<gg<!OgT!osVg<gxOu!
! uqGk<k!lig!ubqX!uql<lq!OlOz!Obh<h!L{<miGl<!
! sgqk<k!Umz<!H{<!OhiOef<K!Kck<Ok!Lbr<gq!hPkqZXl<!
! hGf<k!lzLl<!lih<Ohizh<!hvg<gg<!gpqBl<!kuqk<kqMOl!” 
  
“sqk<kigOu!bqjtg<Gl<!kqm<Mk<!kqm<mi!Lg<Gl<!
! Lk<kig!&g<gqeQI!&{<OmiMl<!.!okk<kivl<!
! lR<sm<!hCv!l{g<Gl<!lkquke!
! uR<sh<!hqvtq!G{liOl!” 
-kqz<!
2/ ubqX!ohiVlq!uQr<gq!Wh<hL{<miGl</!
3/ sqz!Oujt!lzs<sqg<gz<,!sqz!Oujt!lijuh<Ohiz<!gpqk<kz<!
4/ dmz<!H{<Ohiz<!OfiGl</!
5/ hiz<!d{<{iK/!
6/ Olz<!&s<S!d{<miGl</!
7/ dmz<!-jtg<Gl<!
8/ &g<gqzqVf<K!Lk<K!Ohiz<!fQI!ucBl</!
-jubiUl<!hqvtq!g{k<kqe<!GxqgtiGl</!
!
8/!!S,zqg<!g{l<!
! “d{<miR<!S,zqg<!!g{r<!Ogtib<!dx<x!Suisl<!OlozPl<hqx<!
! k{<mi!bqVlz<!lqg!U{<mil<!ke<jl!ofR<S!uib<!lm<Ml<!
! oki{<jm!fiUOl!uf<K!OsiVl<!ohiVL!ubqXh<Hl<!
! u{<miI!LjzBr<!GcbiK!ujgbib<!LgLl<!fiXle<Ox!” 
-kqz<!
2/ &s<Sk<!kq{vz<!d{<miGl</!
3/ uib<,! oki{<jm,! ofR<S! Ngqb! -jugt<! OsiIf<K! OhiG! lm<Ml<!
-Vlz<!d{<miGl<!
4/ ubqX!DKl</!
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5/ hiz<!GcbiK/!
6/ uib<!fix<xl<!wMg<Gl</!
wEl<!-g<Gxqgt<!biUl<!S,zqg<!g{k<kqe<!-bz<hil</!
!
9/ Spq!g{l<;!
“!SpqobEr<!g{Ol!osiz<zqe<!SpqbOu!Suisl<!uir<Gl<!
ftqVme<!SvLl<!Okie<Xl<!fbel<!hR<sjmk<K!gi[l<!
oktqUme<!sf<K!ofif<K!kqjgg<g!ofR<osiqh<H!gi[l<!
! GpqBOl!ds<sq!kipqx<!G{lq0kxqf<K!osiz<Oz” 
 
! “osVL!fijv!Ohix<X!uTl<!OsIg<jg!giZr<!GtqIf<kqVg<Gl<!
! ohiVll<!ubqX!kiE~Kl<!ohiz<zi!SvLl<!lqgU{<mil<!
! niquib<!FjvBr<!OgijpBlil<!nVfiuvTr<!g{<!osiVGl<!
! kvOl!lR<st<!Lg!lbg<gl<!kjzB!OfiuiR<!Spq!g{Ol!” 
-kqz<!
2/ &s<Sk<!kq{xz,<!GtqI!gib<s<sz<!d{<miGl<!
3/ &m<Mgt<!OkiXl<!OfiouMg<Gl</!
4/ kjz!ds<sq!ht<tlib<!Gpq!uqPl</!
5/ uif<kq,!-Vlz<!d{<<miGl</!
6/ Lgl,<!gPk<K,!liIH!-jugt<!uQr<Gl</!
7/ Ljzh<hiz<!Gcg<g!-bzilz<!nzxq!nzxq!uqPl</!
8/ Lgl<!lR<st<!fqxl<!Ohiz!liXl</!
9/ kjz!OfiGl</!
wEl<!-g<Gxqgt<!Spq!g{k<kqz<!gi[l</!
!
:/!lgi!g{l<;!
! “Lgl<!Hxr<!giZl<!jgBl<!OlikqOb!lqElqEg<Gl<!
! fjg!uqpq!outqxqg<!gim<Ml<!fR<S{<mix<!Ohiz<!lbg<Gl<!
! lqg!lqg!ouXh<Hl<!d{<mib<!ouck<K!fidkM!H{<{ib<s<!
! Sglqzi!uVk<kf<!Okie<Xl<!osiz<!lgi!g{k<kqe<!uiOx!” 
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-kqz<, 
2/ Lgl<,! Hxr<giz<,! Hxr<jg! -jugt<! uQr<Gl</! ! nu<uQg<gl<!
lqElqEg<Gl<!
3/ g{<gt<!ouTk<Kg<!gi[l</!
4/ fR<S{<mix<!Ohie<X!lbg<Gl</!
5/ lqGf<k!Svl<!Wx<hMl</!
6/ fi,! dkM! ouck<K! H{<{iGl</! ! -jubiUl<! lgi! g{l<!
GxqgtiGl</!
21/!!DK!g{l<;!
! “!giKme<!g{<[ml<H!g{g<gOu!uQr<Gl<!ux<Xl<!
! OhikOu!fiUl<!H{<{ib<!ohiVf<kqb!SvLl<!d{<mil<!
! OuK!jggiZR<!OsiIf<K!ouTk<kqMl<!ne<ef<!ke<je!!
! DK!fx<!g{lill<!we<Ox!djvk<keI!LequI!kiOl”!
-kqz<!
2/ giK,!g{,<!dml<H!-ju!hPuig!uQr<gq!ux<Xl<!
3/ fig<G!H{<{iGl<,!Svl<!d{<miGl</!
4/ d{U!osz<ziK,!jg,!giz<!OsiIf<K!uqMl<!
5/ dmz<!ouTg<Gl</!
-jubiUl<!DK!g{!GxqG{liGl</!
22/!uvm<!g{l<;!
! “ofR<S!Kcg<Gl<!Hjgf<kqVLl<!fqxLl<!OuOx!figVg<Gl<!
! uR<sl<!nxOu!yV!Oujt!uf<Ok!siQvolzil<!ouKl<Hl<!
! lqR<Sl<!-Vlz<!ubqx<xqjvs<sz<!uqm<Mk<!kqmolb<!KVl<ohMg<Gl<!
! lqR<siI!Gpzib<!uvm<!g{k<kqe<!uiV!lqkje!nxquiOb!” 
-kqz<!
2/ liIH!Kck<kz<!Hjgf<K!-VLkz</!
3/ fi!gXh<H!fqxljmkz<!
4/ ubqx<xqz<!-jvs<sz<!d{<miGl<!
5/ dmz<!olzqf<K!ue<jlBl<!Gjxf<K!uqMl</!
6/ fiuqz<!lR<st<!out<jt!fqxr<gtqz<!Lt<jth<Ohiz<!Okie<Xl</!
 20
7/ &g<gqz<!stq!lqGf<K!&s<jsbjmg<Gl</!
-jubiUl<!uvm<!g{k<kqe<!GxqgtiGl</!
!
23/!!ogikqh<Hg<!g{l<;!
“ofR<S!ogikqg<Gl<!uqzig<!ogikqg<Gl<!OfOv!ofx<xq!uqbIju!uqMl</!
hR<js!Ohiz!g{<!ouTg<Gl<!hiIg<Gl<!OhiK!hz!uqklil<!
KR<S!y{<{i!-Vlz<!uf<K!Kbvh<hm<M!kjz!Ofiuil<!
ogiR<Sr<!GvZr<!gl<lq!uqMl<!ogikqh<H!g{k<kqe<!G{liOl!” 
-kqz<!
2/ ofR<S!uqzi!Ngqbuqmr<gtqz<!nkqg!ogikqh<H!-Vg<Gl<!
3/ ofx<xqbqz<!uqbIju!d{<miGl</!
4/ g{<gt<!hR<S!Ohie<X!ouTk<Kg<!gi[l</!
5/ hiIju!hz!uqklib<!Okie<Xl</!
6/ Gvx<gl<lz<!Wx<hMl</!
-jubiUl<!ogikqh<H!g{k<kqbz<HgtiGl</!
!
24/!!uQg<gg<!g{l<;!
! “uQg<g!g{Ol!osiz<zg<Ogt<!uqiquiBmz!lqgg<!giBl<!
! Osg<G!lu<uu<!uqmf<OkiXl<!osiqbi!lzOl!gm<cuqMl<!
! Ng<G!Lmz!LPkqZOl!biGl<!uQg<gl<!S,mkeiz<!
! Ohig<Gl<!upqjb!g{<mxquib<!HgZLjxbib<!osb<KuqOm! 
-kqz<!
2/ dml<H!LPuKl<!nkqglig!giBl</!
3/ dml<hqz<!nu<uu<uqmr<gtqz<!squf<K!gi[l</!
4/ osiqbilz<!lzl<!gm<Ml</!
5/ S,m<ceiz<!dmz<!LPuKl<!uQg<gl<!gi[l</!
-jubiUl<!uqg<gg<!g{!Gtqgtil</!
!
!
!
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25/!!hqxg<!g{l<;!
! “K~g<gqMOl!lzOhkq!hs<ose<Ox!kie<!
! Okibf<k!kbqI!OhizUOl!ubqX!Lh<hqk<!
! K~g<g!lqGl<!hiz<!nVf<Kl<!gg<Gl<!giBl<!
! osiVgq!uqpq!giz<!jggt<!sqz<oze<Ox!kie<!
! Wx<jgbqOz!kjzHvm<mz<!G{r<gt<!g{<miz<!
! -bz<hie!hqxg<!g{!ole<xqbl<hziOl!” 
 
-kqz<!
2/ hs<jsbigOu! kbqI! Ohie<X! ou{<jlbigOu! gm<cBl<!
fQVliguiuK!ubqX!dh<hq!gpqs<sziGl</!
3/ hiz<!fe<xig!d{<M!dme<!njk!Gpf<jk!gg<gquqMl</!
4/ giz<!jggt<!sqz<oze<xqVg<Gl</!
5/ kjz!Hvm<Ml</!
Ngqb!-g<Gxqgt<!hqxg<g{k<kqbz<hil</!
!
26/!!nf<kg!g{l<;!
! “ds<sq!&jt!kjeh<hx<xq!dmzl<!wr<Gl<!ouKh<H{<mil<!
! lqs<slig!fidzVl<!uqpqgtqv{<Ml<!ouTh<ohb<Kl<!
! hs<js!lR<stK!OhiOz!hSl<!ohie<eqxlib<!LglqEg<Gl<!
! ns<js!HiqB!LjzbiOt!nf<kgg<!g{ole<xxqf<KjvOb!” 
-kqz<!
2/ Svl<!Lkzqz<!ds<sqbqz<!Wx<hm<M!&jtjbBl<!dmjzBl<!hx<Xl</!
3/ fi!dzf<K,!g{<gt<!ouTg<Gl</!
4/ Lgl<!hSl<!ohie<eqxl<!Ohiz!liXl</!
5/ Lgl<!lqElqEg<Gl</!
wEl<!-g<Gxqgt<!nf<kgg{k<kqz<!gi[l</!
!
!
!
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27/!!lf<kiv!g{l<;!
! “lf<kiv!g{k<kqe<!uiX!ujgbxqf<kqmOu!Ogtib<!
! Lf<kqOb!g{L!lif<k!OlikqOb!-jsf<K!%cz<!
! sf<kqbqz<!Svlbg<Gl<!siIf<kqMl<!Suisl<!uir<Gl<!
! gf<kqOb!ubqX!dh<Hl<!g{k<kqz<!lf<kiv!g{Ol!” 
-kqz<!
2/ g{Ll<!lif<kLl<!ye<X!OsIukiz<!lijzbqz<!Svl<!d{<miGl</!
3/ lbg<gl<! uqmilz<! Olz<! &s<S,! ubqX! dh<Hkz<! wEl<! -g<Gxqgt<!
lf<kiv!g{k<kqz<!gi[l</!
!
28/ wiq!g{l<;!
hibqz<!gqmg<g!ym<miK!hjkk<Ok!wiqU!lqgU{<mil<!
uibqz<!&s<Sh<!hxqf<K!uqMl<!uis!dlqp<!fQI!ucf<KuqPl<!
Ofibqz<!hm<M!lqg!nPOl!Ofig<Gr<!gQOp!LgR<sib<g<Gl<!
NBt<!Ouk!juk<kqbVg<!gjxf<Okil<!-KOu!wiqg{Ol!” 
-kqz<!
2/ dmz<!LPuKl<!hMg<g!Lcbikhc!wiqs<sZ{<miGl</!
3/!nu<uzq!giv{lig!Gpf<jk!Kcg<Gl<!
4/ uib<!upqOb!&s<S!uqMl</!
5/ uibqz<!yV!ujg!ouh<H!fix<xLt<t!dlqp<fQI!ucBl</!
6/ Lgk<jk!OfOv!jug<g!Lcbilz<!sib<k<K!juk<K!ogit<Tl</!
-g<Gxqgt<!gi{h<hm<miz<!wiqg{ole<xxqf<K!ogit<tzil</!
!
29/!!fQvil!g{l<;!
! “g{<{QVl<!sQkk<OkiOm!kie<!hs<js!lR<stiGl<!
! g{<{QVl<!hQjt!hib<f<K!gMh<Hme<!uzqk<Ks<!OsiVl<!
! d{<{QV!Lk<Kh<!Ohiz!YmOu!gpqf<k!kigqz<!
! ok{<{Qvil<!fQvilk<jk!wuVtiI!kQIg<g!uz<OziI!” 
!
!
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!
-kqz<!
2/ k{<{QVl<!sQkLl<!gzf<K!gpqBl<!nk<k{<{QI!hs<js!lR<sjt!
njvk<K!gzg<gqb!fQI!Ohie<xqVg<Gl</!
3/ g{<gtqz<!hQjt!OsIf<K!fQI!ucBl</!
4/ ubqX!gMg<Gl</!
5/ Gcg<gqe<x! k{<{QI! nh<hcObi! Gck<kK! Ohiz<! fQvigg<! gpqBl<!
Ngqb!-g<Gxq!G{r<gt<!biUl<!fQvil!g{k<kqe<!-bz<hil</!
!
2:/!!Nl!g{l<;!
! “Nl!g{k<kqe<!G{r<Ogtib<!njmujmbig!ouKl<hiK!
! silf<!OkiXl<!ouKl<hq!fqx<Gl<!k{<{QI!dpjz!d{<miGl<!
! Oslk<Kmz!lqg!-jtg<Gl<!sQxqbPOl!hsqbqz<jz!
! filf<!ktVl<!-K!kiEl<!fMr<gqbqVg<Gr<!g{<miOb!
-kqz<!
2/ Svl<!dmzqz<!Okie<Xl</!
3/ ns<Svl<! WXuKl<,! -xr<GuKlig! -Vh<hOkiM! yu<ouiV! sill<!
uqm<Ml<!gib<uKlig!-Vg<Gl</!
4/ dmz<!lqg!-jtg<Gl</!
5/ sQxqs<!sQxqbPl<!ubqX!OhkqbiGl</!
6/ liIH!Kcg<Gl</!
7/ sqXfQI!lR<st<!fqxlib<!-xr<Gl</!
8/ gPk<K!dml<H!-u<uqmr<gtqz<!-bx<jg!fqxl<!liXl</!
9/ &g<G!OlZg<G!gqtl<hq!gim<Ml</!
:/ dml<H!-jtk<K!KVl<H!OhiziGl</!
!
31/!!&g<Gg<!g{k<kqe<!Gxq!G{l<;!
! “Osiglib<!fig<G!ouf<K!SvLml<!kjzb!fi{qk<!
! kiglib<!ubqx<jx!hx<xq!kie<!sQkl<!vk<kl<!uQPl<!
! liglib<!dXh<H!kt<tq!liVm<mZmz<!fMg<gz<!
! OkijgOb!Ogtib<!Lg<G!g{oles<!osiz<ZuiOb!
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! gg<G!LjzBl<!d{<{iK!giZr<!jgBr<!GtqIf<kqVg<Gl<!
! osig<Gl<!dmZl<!g{<!OsiVl<!okig<G!lqjtg<G!Lmz<!gXg<Gl<!
! fqx<Gl<!gMg<Gl<!Nseuib<!ofVh<H!hm<mix<!Ohiz<!wiqBl<!
! Lg<Gg<!g{k<kqe<!G{lqoke<X!oliqf<Okil<!-kje!hiviOb!” 
-kqz<!
2/ fi!ouf<K!H{<{iGl,<!kig!L{<miGl<!
3/ sQkLl,<!-vk<kLlig!ubqX!gpqBl<!
4/ lzuib<!Lg<gq!Lg<gq!outqbqz<!uVl</!
5/ Nse!uib<!gMg<Gl</!
6/ dmz<!-jtk<Kg<!gXg<Gl<!
7/ ofVh<Hh<!hm<mix<!Ohie<X!Nseuib<!wiqBl<!
8/ jgBl<,!giZl<!GtqIf<kqVg<Gl<!
-jubiUl<!Lg<Gg<!g{k<kqeqbz<Hgtil</!
32/!&zg<!g{l<!
! “nkQkl<hiI!&zg{Ol!oke<xg<giz<!
! nk<kqbqOz!uik!hqk<k!lkqgligq!
! nkQkl<!hiI!sQkLme<!vk<k!Lx<Xl<!
! nkqZjts<s!zisek<kqz<!gix<X!Olir<Gl<!
! nkQkl<!hiI!SvLmOe!ubqx<xqjvs<sz<!
! nkqg!kjz!Ofib<!uVl<!uqmiK!hivib<!
! nkQkl<hiI!s{<mit!&zOvigl<!
! nkm<MOl!hk<ki{<M!lm<Ml<!hiOv!” 
-kqz<!
2/ utqBl<! hqk<kLl<! lqGf<K! wZl<hqx<OsIf<K! nkeiz<! &zk<kqz<!
ogikqh<H{<migq!H{<hm<M!sQkLl<!-vk<kLlib<!gpqBl</!
3/ Nsek<kqz<! gix<X! OsIf<K! ogi{<M! hmhmoue<x! yzqBme<!
outqh<hMl</!
4/ Svl<!lqGkqbig!kjz!Ofikz</!
Ngqb!-g<GxqG{r<gt<!biUl<!&zg{liGl</!
!
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33/!!Ohvil!g{l<;!
! “jgBme<!giz<!GtqIf<K!g{<[Ol!ujtbliGl<!
! Gb<bOu!SvLl<!!Okie<Xl<!Gck<k!hiz<!sIk<kq!h{<[l<!
! Kb<bOu!kqMg<gqm<Omr<Gl<!OsiIf<K!kie<!ubqX!
! ohib<bz<z!Ogtibqf<k!Ohvil!g{k<kqe<!uiOx!
! !
Ohvil!G{Ol!OgT!ohiVlqMl<!ubqX!kt<Tl<!
! Ofvig!ubqX!OhiGl<!ofx<xqbqz<!uzqh<Hk<!Okie<Xl<!
! sQvig!LjzB{<{iK!sQxqOb!ouVuqh<!hiIg<Gl<!
! giI!Gpz<!kek<kqeiOz!g{<mkqg<!G{r<gt<!kiOe”!
-kqz<!
2/ jg!giz<gt<!GtqIf<kqVg<Gl<!
3/ hiz<!osiqbiK,!Gck<khc!uif<kqbiGl<!
4/ ubqX!ohiVlq!lzl<!outqh<hMl<!
5/ ofx<xqbqz<!uzq!wMg<Gl<!
6/ hiz<!Gcg<giK!
7/ hbf<k!hiIjubib<!gi[l</!
!
34/!!-vk<k!g{l<;!
! “-jmuqmi!Lg<gq!Lg<gq!bqVlZr<!gpqs<sZ{<mil<!
! njmhmi!gpqs<szigq!bcg<gc!bqvk<kr<!gi[l<!
! okijmbqjm!uzqg<Gf<!kigl<!osiz<ozi{i!SvLr<giBl<!
! kjmhmi!uqbikq!obe<Xl<!six<xqeI!LequI!kiOe!
!
! fic!nbIf<Ok!Btl<!uic!olk<kU!fis!hsq!
! %cbsel<!Hsqg<g!ouim<miK!Gpf<jkgm<Og!
! Ycb!vk<k!lzf<keqx<!OsIf<KX!&zlkiz<!
! sicg<Gl<!vk<kg{oleOu!Leq!six<xqeOv!” 
!
!
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-kqz<!
2/ Gpf<jk!-jmuqmilz<!Lg<Gl</!!Lg<Gl<!OhiK!-Vlz<!Wx<hMl</!
3/ -vk<klig!gpqBl</!
4/ okijm!-Mh<H!Ngqb!-mr<gtqz<!uzq!d{<miGl</!
5/ Svl<!kigl<!leuim<ml<!-Vg<Gl</!
6/ hsqbqe<xq!-Vk<kz<!d{U!d{<{!-bzijl!
7/ fic!fjm!nbIf<K!olzqf<K!gim<Ml</!
wEl<!-g<GxqG{r<gt<!-vk<k!g{k<kqe<!-bz<hiGl</!
!
35/!sqr<gqlif<k!g{l<;!
“Ohvie!sqr<gq!lif<k!g{k<jk!Ogtib<!
! ohVjlbib<!df<kqk{z<!OlozPl<hq!
! uivie!=vZOl!H{<{ib<!ouf<K!
! uZjlbib<!SuisOlz<!-Ph<Hligqs<!
! sQvie!OkgR<s&zr<!gib<f<K!
! squ!squi!kpz<!OhiOz!SvLl<!uQSl<!
! uQvie!Suis!lK!kqg<G!Lg<gic!
! ouGtqbib<!lbg<Guqg<GR<!sqr<gq!g{l<!hiOv!” 
-kqz<!
2/ df<kqbqzqVf<K!yV!ujgs<S,M!OlozPl<Hl<!
3/ =vz<!ouf<K!H{<hMl</!
4/ gcelig!Olz<!&s<S,!-Ph<H!-ju!d{<miGl</!
5/ dmz<!uxm<sqbjmf<K!Svl<!Wx<hMl<!
6/ &s<S!kmr<gz<!Wx<hm<M!lbg<gl<!uVl</!
-f<Ofib<! Olx<gi[l<! GxqG{r<gTme<! Gpf<jkgjt!
he<eqv{<mi{<M! ubK! ujv! ujkg<Gl<! we! hizuigml<!
-bl<HgqxK/!
! -r<rel<! g{k<kqe<! 35! ujggTl<! nkeke<! GxqG{r<gTg<G!
Wx<h!ujgh<hMk<kq!keqk<K!jug<gh<hm<Mt<tK/!
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IV/!!Lg<Gx<xl<!Lkzqb!OuXhiMgt<!
! uikl<! hqk<kl<! ghl<! Ngqb! &e<X! dbqi! kiKg<gtqe<! sls<sQI!
fqjzbqz<! d{<miGl<! OuXhiMgt<! Ofibig! dx<hk<kqbigqxK! we<X!
sqk<k!lVk<Kul<!%XgqxK/!
!
! hizIgtqz<!d{<miGl<!“g{l<”!wEl<!OfibieK!
! “fMr<gqbOkiI!hqk<klK!Ogihr<!ogi{<M!
! fz<zuiBju!hx<xq!bPk<kqg<!ogit<Tl<!
! gcf<kqVf<k!hqt<jtg<G!gkqk<k!%,M!
! gegeh<H!wf<Ofvr<!jguqmiK”!
.!hizuigml<!;!hg<gl<!291/!
! n0kiuK!npz<!Gx<xl<!ke<etqz<!lqGf<K!uiBju!hx<xq!nPk<kq!
ogit<Tl</! Nkeiz<! dmzqz<! nkqgh<hm<m! npz<! k{qukx<G!
upqbqz<zilz<!Gpf<jkg<G!nkqgligs<!S,M!d{<migq!dmz<!g{g{h<H!
Wx<hMgqxK/!
!
V/!hq{qbxq!Ljxjl!(Diagnosis) 
! sqk<klVk<Ku! Ljxbqz<! Ofib<! g{qh<hkx<G! gQp<gi[l<! uqkqLjxgt<!
hqe<hx<xh<hMgqxK/!nju!
!
2/ ohixqbiz<!nxqkz<!)hiIjubiz<!nxqkz<*!
3/ Hzeiz<!OkVkz<!)okim<M!hiIk<K!nxqkz<*/!
4/ uqeikz<!)Ogt<uqgt<!&zl<!nxqkz<*!
!
Ofibqeje! hiqOsikje! Olx<ogit<Tl<! OhiK! Olx<gi[l<!
kjzh<Hgtqz<! keq! guel<! osZk<kq! Ofijb! g{qg<g! Ou{<MuK!
nusqbliGl</!
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n0kiuK!olb<,!uib<,!g{<,!&g<G,!osuq!Ngqb!Jf<K!ohixqgjtg<!
ogi{<Ml<! Ofibqje! OfVg<G! ofI!uqeikz<! ogi{<Ml<! Ofib<! g{qg<gh<hmz<!
Ou{<Ml</!
uqeikzqz<! Ofibqeeqe<! Ke<hr<gtqe<! ntU,! gizl,<! kx<Ohijkb!
Ofibqe<! uvziX,!Lf<jkb! Ofib<gtqe<! uvziX,! Ofibqee<! usqg<Gl<! -ml<,!
nK! siIf<k! kqj{,! Ofibqeeqe<! ohiVtikiv,! s&g! Oll<him<ce<! fqjz!
(Socio- economic status) Ngqb!-jugt<!uqeikz<!&zl<! Ogm<M!oktqbh<hm!
Ou{<cb!nl<sr<gtiGl</!
Olx<gi[l<! ohixq,! Hze<gtiz<! nxqkz<,! uqeikz<! -jubiux<jxBl<!
lVk<KuviBkl<! weh<hMl<! w{<ujgk<! OkIUgt<! &zl<! dXkqhMk<k!
Ou{<MuK!sqk<k!lVk<Ku!lvH/!
!
“fic!hiqsl<!fi!fqxl<!olipq!uqpq!
lzl<!&k<kqvlqju!lVk<KuviBkl<”!
! ! ! ! ! .!Ofib<!fimz<!Lkz<!higl</!
! ! ! ! ! ! ! )hg<gl<*!
VI/!!w{<ujgk<!OkIUgt<;!
! wm<M!OuXhm<m!Osikjegjt!Ofibqee<!hiz<!Olx<ogi{<M!lVk<Kue<!
Ofibqje!g{qg<Gl<!LjxjlOb!w{<ujgk<!OkIUgtil</!njubiue!
! fic! ! ! hiqsl<!
! fi! ! ! fqxl<!
! olipq!! ! uqpq! !
! lzl<! ! ! &k<kqvl<!
! “Okcb!uqbikqg<!ogz<zil<!Okgk<kqz<!hiQm<jsB{<M!
! %cOb!fqx<Golm<M!hiqm<jsbir<!%xg<OgtQI!
! ficOb!okim<mix<!Okgl<!&k<kqvl<!uiIk<jk!g{<gt<!fig<G!
! hicOb!lzszr<gt<!hz!u{<{l<!hiIk<Kg<!ogit<Ot”!
! ! ! ! ! ! ! .!sqk<k!lVk<Ku!l{qgt<!
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VIa/!g{Ll<<<,!w{<ujgk<!OkIUgTl<!
! w{<ujgk<! OkIUgtqe<! nch<hjmbqz<! g{l<! g{qg<gh<hmzqe<! uqhvl<!
%xh<hMgqxK/!
2/!!fic;!
! fic!we<hK!w{<ujgk<!OkIugtqz<!hqvkielie!ye<xiGl</!!hq{qjb!
ficbzxqf<K!lVf<K~m<MkOz!sqxf<kK!we<X!sqk<k!lVk<Kul<!%XgqxK/!
! “Lh<hq{q!lVuq!LeqU!ogit<!Gxqh<jh!
! kh<hikxqBl<!ke<jlBl<!uik!hqk<kjubh<!hqiqjuBlqjukil<!
! Wxqbqxr<gq!-j{f<K!gzf<K!lixqlixq!uVR<osbx<jgbix<!hqeq!
! OfIjl!bxqf<K!fQm<M!lVf<Ok!sQiqb!kioles<!osh<HuI!sqk<kOv” 
. sqk<k!lVk<Ku!Ofib<!fimz<!Ofib<!Lkeimz<!
. kqvm<M!–!higl<!.!I!
Nbqe<! Gpf<jkgtqz<! fic! fjm! ogi{<M! Ofib<! g{qg<g! -bZkz<!
sx<X! gcelie! ye<xiGl</! ! Woeeqz<! Gpf<jkgtqz<! fic! fjm! siqbigk<!
Okie<xiK!we<hjk/!
“ogi{<cmOu!gbOvigq!gisOvigq!
Gxqh<hig!sqx<xqe<hl<!osb<k!OhIgt<!
n{<cmOu!kiqk<kqvIgt<!uqVk<kI!hizI!
ogi{<cmOu!-uIgtqz<!dXh<hqe<!kiK!
%xOu!LcbiK!wuIg<Gl<!gqm<Ml<…/!
! ! .!sqk<k!lVk<Ku!Ofib<!fimz<!Ofib<!Lkeimz<!kqvm<M!
! ! .! higl<!.!2/!
-Vh<hqEl<,! g{k<kqz<! hqk<k! ficbieK! hikqk<K!uikk<jkBl<! Kj{!
ogit<ukiz<!“hqk<k!uik!fic”!Okie<xq!fqx<gzil</!
-r<G! Nb<uqx<G! dm<hMk<kh<hm<m! hizIgtqz<! lqGkqbiOeiI! gTg<G!
hqk<kuikfic! fjm! gi{h<hm<mK/! ! OlZl<! uikhqk<kfic! gi{h<hm<mK/!!
-f<fic! fjmbieK! Lbe<x! ntuqz<! OkIuitiviz<! hiqOsikqk<K!
wPkh<hm<Mt<tK/!
!
!
 30
3/!!hiqsl<;!
! Ofibqje! okim<M! hiIk<kzqe<! Ohiqz<! Okizqe<! osivosivh<H! ke<jl!
dmx<gir<jg,! lqVK! ke<jl,! uqbIk<kz<,! dzIkz<,! uQg<gl,<! kch<H Ngqb!
-jugjt!hiqsk<K!d{vzil</!
!
! g{Ovigr<!g{<m!Gpf<jkgtqz<!-r<G!Nb<uqx<Gm<!hMk<kqbuIgtqz<!
2/ npz<!nkqgliekiz<!dmz<!g{g{h<Hl<!S,Ml<!d{<mibqVf<kK/!
3/ Lgk<kqz<!uqbIju!
4/ jg,! giz<gt<,! Lgl<! -ju! gVk<kqVk<kZl<! sqz! Gpf<jkgtqz<!
wiqf<Kl<,!GtqIf<Kl,<!ouKl<hqBl<!gi{h<hm<mK/!
5/ nez<!uQSuK!Ohie<x!dm<Svl<!Ngqb!-jugt<!keqk<Kl<!gzf<Kl<!
gi{h<hm<mK/!
!
4/!!fi!
! fiju! hiqOsikjeg<G! dm<hMk<kqbkqz<! g{l<! g{<m! Gpf<jkgtqz<!
sqziqz<!
2/ fi!ux{<Ml</!
3/ fiuqZl<!gjmuibqZl<!H{<!d{<migqBl<!
4/ uib<!fix<xk<KmEl</!
OuX!sqziqz<!
2/ uib<!fix<xk<Kme<!Olz<!uib<!ouck<K!H{<[mEl<!
3/ fi!Oug<giMmEl<!
4/ uib<!dzIf<K!fQI!Oum<jgBmEl<!gi{h<hm<meI!
5/ fqxl<;!
! -kqz<! Okizqe<! fqxl<,! uik,! hqk<k,! ghr<gtqe<! GxqgTme<! gi{zil</!!
OlZl<! Okizqz<! fQzl<! hiiqk<kz<,! lR<stqk<kz<! gVfqxl<! njmkz<! Ngqb!
Okizqe<!lix<xr<gjt!g{qg<gzil</!
! g{l<! g{<m! Gpf<jkgtqe<! dmz<! fqxlieK! sqziqz<! squf<Kl<,!
outqxqBl<!gi{h<hm<mK/!
!
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6/ olipq;!
2/ g{l<! OfiBx<x! Gpf<jkgtqz<! ghl<! nkqgiqk<K! liIhqZl<!
oki{<jmbqZl<! stq! gm<Mukiz<! oki{<jm! gl<lz<! d{<migq!
Gvz<!kip<f<K!OhSl</!
3/ gI!gI!wEl<!yzqBmEl<!-VlZl<!gi{h<hm<mK!
7/ uqpq;!
g{l<!g{<m!Gpf<jkgtqz<!
b/ g{<gtqe<!fqxl<!-bx<jg!fqxk<kqx<G!lixq!gi{h<hm<mK/!
c/ g{<gt<!ouV{<M!hiIk<kK/!
d/ g{<!wiqs<sz<!lijz!Oujtgtqz<!gi{h<hm<mK!
e/ g{<gt<!squf<K,!wiqf<Kl<!gi{h<hm<mK!
f/ out<uqpq!sqziqz<!ouTk<K!gi{h<hm<mK/!
8/ lzl<!;!
! Nb<uqx<Gm<hMk<kh<hm<m! 46! g{Ofibqeiqe<! lzk<kqe<! OuXhiMgt<!
gQp<g{<muiX!njlf<kqVf<kK/!
2/ lzl<!w{<o{b<!gsqUt<tkigUl</!
3/ sqz!Gpf<jkgtqz<!sQkligUl,<!-vk<kligUl<,!-v{<Ml<!gzf<Kl</!
4/ sqziqz<!lzl<!OuX,!k{<{QI!OuvigUl</!
5/ sqz!Gpf<jkgtqz<!lzl<!outqh<hmiK!lzgm<MmEl<!gi{h<hm<mK/!
9/!!&k<kqvl<;!
! g{k<kqz<!dm<hMk<kh<hm<m!Nb<U!Ofibitqgtqz<!ohVl<hiOzieiqz<!
2/ sqXfQI!SVr<gqBl<!lqg<g!wiqs<sOziMl<!-xr<gqBt<tK/!
3/ sqzVg<G!fQI!SVg<G!d{<migqbqVf<kK/!
-kqz<!npz<!Gx<xk<kqe<!lqGkqbqe<!ntuig!dmzqz<!dt<t!fQIux<xq!sqXfQI!
SVg<G!d{<migzil<!we<X!sqk<k!lVk<Ku!F~x<gt<!hgVl</!
!
!
!
!
!
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fQIg<Gxq!ofb<Gxq!
n/!fQIg<Gxq;!
! “uf<k!fQI!giqobjm!l{l<!Fjv!wR<soze<!
! jxf<kqbZtju!bjxK!LjxOb”!
! ! ! .!Ofib<!fimz,<!Lkz<!higl<!
we<xkiz<!-kqz<!fqxl<!l{l<!Fjv!wR<sz<!wjm!Ngqb!-jugjt!Ofig<g!
Ou{<Ml</!
! G{l<! g{<m! Gpf<jkgtqz<! npz<! nkqgliukiz<! “sqXfQI! SVg<G”!
Wx<hMl<!we!hizuigml<!%XgqxK/!
! Nb<uqz<! Gpf<jkgt<! sqziqz<! sqXfQI! lR<stqk<Kl<! sqz! Gpf<jkgtqz<!
fQI!wiqs<sZme<!squf<K!-xr<gqbkigUl<!gi{h<hm<mK/!
!
N/!ofb<g<Gxq;!
! wg<Gx<xl<!ke<eqjz!lqGf<Kt<tK!we<hkje!“g{l<“!Ofibqeeqe<!
sqXfQiqe<! ofb<g<Gxq! &zl<! d{vkz<! WKuigqxK! we<X! -s<Osikje!
Olx<ogit<th<hm<mK!
! g{Ofibitqbqe<! sqXfQjv! Osikje! um<czqz<! Dx<xq! ytqlqGf<k!
-mk<kqz<!juk<K!fz<oz{<o{b<!2!Ktq!uqm<M!hiIg<gh<hm<mK/!
! n0K! sqziqz<! Npq! )Olikqvl<*! Ohie<X! hvuqBl<! lqg! hzVg<G!
Lk<K!Ohie<Xl<!fqe<xK/!
! “nvoue!fQ{<cce0Ok!uikl<!
! Npq!Ohix<!hvuqe<!n0Ok!hqk<kl<!
! Lk<okik<K!fqx<gqe<!olipquoke<!ghOl”!
! ! ! ! ! .!Ofib<!fimz<!Lkz<!higl<!
we<hK! ofb<Gxqbqe<! sikiv{! OkIU! LjxbiGl</! ! -ke<! upq! uik!
hqk<k!gh!Ofib<gtqe<!ke<jljb!nxqb!LcgqxK/!
!
!
!
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VII/!g{k<kqz<!WP!dmx<gm<Mgtqe<!fqjz;!
! dmz<! kiKg<gt<! we<xjpg<gh<hMl<! WP! dmx<gm<Mgtiue! ;! sivl<,!
osf<fQI,!De<,!ogiPh<H,!we<H,!&jt,!Sg<gqzl<!)n*!SOvi{qkl<!we<heuil</!
! d{<m!d{uqe<!ne<evslieK!Gmzqz<!dxqR<sh<hm<M!nK!dml<hqz<!
Ohi]qg<gh<hm<M! yu<ouiV! fiTl<!LjxOb!GVkq!Lkzie!dmx<gm<Mgtig!
ye<xe<hqe<! ye<xig! liXgqxK!we<X! sqk<k! lVk<Ku!dmz<! kk<Ku!F~x<gt<!
%XgqxK/! ! weOu,! -ju! WPl<! dmzqe<! -br<G! fqjzgtqz<! sls<sQI!
fqjzbqz<!juk<K!ogit<gqxK!we<hK!nxqf<kokie<xiGl</!
! “g{l<”! Ofibqeiz<! hikqg<gh<hm<m! Ofibitqbqe<<! dmx<gm<Mgtqe<!
fqjzgjt!gueqg<g!Ou{<MuK!-e<xqbjlbikkiGl</!
2/!!sivl<;!
! g{l<! Ofib<! ! g{<m! Gpf<jkgtqz<! d{uqz<! ouXh<H,! hsqbqe<jl,!
ubqX! gpqkz<! Ohie<x!GxqG{r<gt<! oke<hm<mkiz<!ne<evsl<! -bx<jgbie!
Ljxbqz<!gqjmg<g!ohxilz<!sivl<!hikqh<hjmf<K!gi{h<hm<mK/!
3/!!osf<fQI;!
! osf<fQVl<!g{!Ofibqeiqml<!hikqg<gh<hm<M!gi{h<hm<mK/!!nbosf<kut!
GjxU!nOeg!Ofibitqgtqml<!gi{h<hm<mK/!
4/!!De<;!
! g{!Ofibitqgtqml<!dmz<!olzqf<Kl<!dmz<!ux<xqBl<!ux{<Ml<!De<!
hikqg<gh<hm<M!gi{h<hm<mK/!
5/!ogiPh<H;!
! dml<H! uxm<sqBx<X! olzqf<K! gi{h<hm<mkiZl<! kjsgt<! ux<xq!
gi{h<hm<mkiZl<!ogiPh<H!njeuiqZl<!hikqg<gh<hm<M!gi{h<hm<mK/!
6/!!we<H;!
! sqz! Ofibitqgtqml<! ofR<ose<H! %l<H! Ohiz<! wPl<hq! fqe<X! we<H!
hikqh<hjmf<kqVf<kK/!
7/!!&jt;!
! /-0K!wf<k!OfibqeeqmLl<!hikqh<H!gi{h<hmuqz<jz/!
!
!
 34
8/!!Sg<gqzl<!)n*!SOvi{qkl<;!
! Nb<uitI! Nb<uqx<G! wMk<Kg<! ogi{<m! OfibqeI! biuVl<! hizIgt<!
Njgbiz<! Sg<gqz! SOvi{qkr<gtqe<! liXhiMgjt! g{<mxquK!
sik<kqblqz<jz/!
!
!
!
!
lVk<Kul<!Treatment 
Azhal Kuttram and Vatha Kuttram are vitiated in Kanam. Associated the 
Signs and symptoms of Kapa derangement is also appreciated in Kanam via., 
cough and expectoration. So, the vitiated kuttram is to be brought back to normal 
condition by administrating of vomiting (or) purgative. In this connection, drug 
give for vomiting and purgation is though to be contradictory in siddha view. 
 
So that we can administer the drugs directly to the Kanam affected children. 
 
The are several medicines stated in various siddha texts for Kanam, among 
them Madhulai Nei is selected for the treatment. 
 
Madhulai nei is well mixed with the well - boiled hot milk. It is given for 
two times. (ie. early morning and in evening after food ) a day. 
The dosage of Medcine in different age group is given in the Table 1. 
 
The Methods of preparation of Medicine and other details are given in  
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Annexure – I. 
 
The dosage of medicine in different age group. 
Table 1 
S.No. Age Group Dosage 
1. 3 to 4 years 4 ml. 
2. 5 to 7 years 8 ml. 
 
In connected with this dissertation drug is administrated the patients those who are 
sufferings from kanam, the dosage of medicine and duration of the treatment is 
charted below. 
 
Dose: gv{<c!ntU! (4 ml.) Early morning and evening 
 
Days: 41 days (According to Balavagadam Text). 
 
 The above medicine is continuously administrated for 41 days in each case, 
and the result in dealt with results and observation. 
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B. MODERN ASPECT 
PRIMARY COMPLEX 
 
MYCOBACTERIAL INFECTIONS 
ETIOLOGY: 
 There are five closely related mycobacteria in the Mycobacterium 
tuberculosis complex: M. tuberculosis, M. bovis, M. africanum, M. microti and  
M. Canetti.  M.tuberculosis is the most important cause of tuberculosis disease in 
humans.  The tubercle bacilli are non-spore-forming, non-motile, pleomorphic, 
weakly Gram – positive curved rods 2-4µm long.  They may appear beaded or 
clumped in stained clinical specimens or culture media. 
PATHOGENESIS: 
 The primary complex of tuberculosis includes local infection at the portal 
of entry and the regional lymph nodes that drain the area.  The lung is the portal of 
entry in over 98% of cases.  The tubercle bacilli multiply initially within alveoli 
and alveolar ducts.  Most of the bacilli are killed, but some survive within 
nonactivated macrophages, which carry them through lymphatic vessels to the 
regional lymph nodes.  When the primary infection is in the lung, the hilar lymph 
nodes usually are involved, although an upper lobe focus may drain into 
paratracheal nodes.  The tissue reaction in the lung parenchyma and lymph nodes 
intensifies over the next 2-12 week as the organism grows in number and tissue 
hypersensitivity develops.  The parenchymal portion of the primary complex often 
heals completely by fiberosis or calcification after undergoing caseous necrosis 
and encapsulation.  Occasionally, this portion continues to enlarge, resulting in 
focal pneumonitis and pleuritis.  If caseation is intense, the center of the lesion 
liquefies and empties into the associated bronchus, leaving a residual cavity. 
 The foci of infection in the regional lymph nodes develop some fibrosis and 
encapsulation, but healing is usually less complete than in the parenchymal lesion.  
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Viable M. tuberculosis can persist for decades within these foci.  In most cases of 
initial tuberculosis infection the lymph nodes remain normal in size.  However, 
hilar and paratracheal lymph nodes that enlarge significantly as part of the host 
inflammatory reaction may encroach on a regional bronchus. Partial obstruction of 
the bronchus caused by external compression may cause hyperinflation in the 
distal lung segment.  Complete obstruction results in atelectasis.   Inflamed 
caseous nodes can attach to the bronchial wall and erode through it, causing 
endobronchial tuberculosis or a fistula tract.  The caseum causes complete 
obstruction of the bronchus.  The resulting lesion, a combination of pneumonitis 
and atelectasis, has been called a collapse-consolidation or segmental lesion. 
 
 During the development of the primary complex, tubercle bacilli are carried 
to most tissues of the body through the blood and lymphatic vessels.  Although 
seeding of the organs of the reticuloendothelial system is common, bacterial 
replication is more likely to occur in organs with conditions that favor their 
growth, such as the lung apices, brain, kidneys, and bones.  Diseeminated 
tuberculosis occurs if the number of circulating bacilli is large and the host cellular 
immune response is inadequate.   More often the number of bacilli is small, 
leading to clinically inapparent metastatic foci in many organs.  These remote foci 
usually become encapsulated, but they may be the origin of both extra pulmonary 
tuberculosis and reactivation tuberculosis in some individuals. 
 
 The time between initial infection and clinically apparent disease is 
variable.  Disseminated and meningeal tuberculosis are early manifestations, often 
occurring within 2-6 months of the infection.  Clinically significant lymph node or 
endobronchial tuberculosis usually appears within 3-9 months.  Lesions of the 
bones and joints take several years to develop, whereas renal lesion may become 
evident decades after infection.  From 25-35% of children with tuberculosis 
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develop extrapulmonary manifestations compared with about 10% of 
immunocompetent adults. 
 
 Pulmonary tuberculosis that occurs more than a year after the primary 
infection is usually caused by endogenous regrowth of bacilli persisting in 
partially encapsulated lesions.  This reactivation tuberculosis is rare in children but 
is common among adolescents and young adults.  The most common from is an 
infiltrate or cavity in the apex of the upper lobes, where oxygen tension and blood 
flow are great. 
 
The primary complex: 
 The inflamed area at the point of entry of tubercle bacilli is called the “primary 
focus”.  Its size varies from a few mm to 1 or 2 cm.  Some tubercle bacilli traverse to the 
regional lymph nodes via the draining lymphatic vessels and cause an inflammatory 
reaction there.  The primary focus, the draining lymphatics and the inflamed regional 
lymph nodes are collectively called the ‘primary Complex’. The degree of enlargement of 
the lymph nodes and the symptoms in the child are the expressions of the degree of 
infection and the degree of sensitivity produced.  The regional glands become enlarged 
and caseous.  Occasionally there may be an associated pleural reaction,.  Thus it will be 
seen in mathematical terms; Primary complex – Primary focus + Regional lymphatic + 
Regional lymph nodes + Pleural reaction. 
 The inflammatory reaction in the regional nodes is generally more marked than 
that in the primary focus.  In four – fifth of cases, there is only one primary lesion 
but in the rest there may be more than one tuberculous focus. 
 
 The areas of maximum ventilation in the lungs are the usual sites of the 
primary lesion and thus the latter are often present in midzones of the lungs where 
there are marked respiratory excursions.  As the right lung accounts for about 3/5 
of the total effective pulmonary volume and as the right bronchus is more vertical, 
short and wide, the right side of the chest is affected more often than the left.  As 
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the air current in the peripheral parts of the lungs is more sluggish and the bacilli 
stay there longer, the primary focus is generally located peripherally in the sub 
pleural region. 
 
COURSE OF THE PRIMARY COMPLEX 
Further development of the primary complex depends on the host defense. 
 
1. If the resistance of the host is good and environment is favorable, the 
exudates around the primary focus is absorbed and the caseous area is 
inspissated.  Healing occurs by fibrosis and calcification. 
 
2. When the host defenses are poor and the conditions are unfavorable, the 
inflammatory process extends in the contiguous area (Progressive primary 
tuberculosis).  The inflamed area in the primary focus and regional lymph 
nodes may merge and present as an area of consolidation on the X-ray film. 
 
3. The caseous area in the lesion may liquefy due to the action of the proteolytic 
enzymes liberated from the dead neutrophils.  The liquefied material may be 
expectorated out and a cavity with shaggy margins may be left behind in the 
parenchyma of the lung. 
 
4. The inflamed lymph nodes may compress the neighboring bronchus.  If the 
obstruction is incomplete, it may act like a ball valve.  The air is trapped 
distal to the occlusion and obstructive emphysema may supervene.  The lung 
parenchyma distal to the site of compression becomes atelectatic if the 
bronchial obstruction is complete. 
 
5. The caseated lymph node may erode through the walls of the bronchus.  
Involvement of the bronchial mucosa causes tuberculous bronchitis.  
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Eventually, fibrosis and bronchiectatic changes may supervene.  The 
discharge of the tubercle bacilli into the bronchial lumen leads to 
bronchogenic dissemination of infection. 
 
6. Some tubercle bacilli reach the blood stream via the chain of lymph nodes.  
This occult hematogenous dissemination occurs early in the course of the 
disease.  Some of these tubercle bacilli may die; others may form tubercles in 
the organs with a high degree of susceptibility.  Such metastatic lesions may 
not develop into disease if the host factors are able to overcome the 
inflammatory responses.  During early bacillemia, seeding may occur in apex 
of lungs.  This is called Simon’s focus.  If the local resistance is lowered due 
to malnutrition or other intercurrent disease, the metastatic foci may extend 
and cause tuberculous disease. 
 
7. In overwhelming infection, the caseous node may erode a blood vessel and a 
large number of tubercle bacilli may enter the circulation.  A single massive 
seeding of circulation with tubercle bacilli causes miliary tuberculosis.  All 
the lesions are of almost similar size and age.  Recurrent dissemination of 
tubercle bacilli may lead to metastases of varying sizes. 
Miliary and meningeal tuberculosis usually occur within a year of the primary 
lesions. 
This first infection of the body is known as primary infection.  The primary 
complex will have the same features whatever the organ of the body where 
this primary infection takes place.  After the first few months of primary 
infection, the tubercle bacilli enter the lymphatics and then the bloodstream 
via the thoracic duct to be carried into different parts of the body.  Depending 
upon several factors such as host resistance, dose of bacilli, their virulence 
and sensitivity and the child’s age, the further development may be one of 
natural arrest or the disease progressing to various complications.   
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DISSEMINATION: 
 After the formation of the primary complex the individual child goes 
through a period of maximal danger during which the risk of local or disseminated 
complication is the greatest.  The risk is maximal in the first three months in the 
young child.  Enlargement of the regional glands being the most important 
consequence of primary tuberculosis.  Softening of the gland occurs within a year 
of primary infection or following intercurrent infections like streptococcal sore 
throat or measles.  Erosion of the caseous material into a vessel produces heavy 
dissemination of bacilli at a time favorable to the organism. 
 
POST-PRIMARY, SECONDARY OR REACTIVATION: 
 Late post – primary disease is rare in children below the age of five years.  The 
presenting symptoms are cough, sputum, hemoptysis, loss of appetite, etc as in adults.  
The physical signs may reveal the presence of consolidation or cavitation.  These 
children run the risk of hemoptysis and severe lung damage with fibrosis.  Perforation 
of a bronchus may rarely occur, with violent bouts of coughing, choking, cyanosis and 
death. 
 The involvement of the other mediastinal structures is as follows: 
1) Oesophagus:  Mediastinal nodes may cause compression or 
displacement of oesophagus (causing dysphagia and vomiting).  
Rarely, perforation of the oesophagus may result in oesophago – 
mediastinal pulmonary fistula. 
2) Nerves: Recurrent laryngeal nerve involvement may result in vocal 
cord paralysis and hoarseness of voice. 
3) Phrenic nerve:  The left phrenic nerve may be involved with the 
elevation of the left hemi-diaphragm. 
4) Horner’s Syndrome may rarely occur due to the involvement of the 
sympathetic chain. 
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5) SVC Obstruction syndrome: Large Para – tracheal nodes may 
compress the SVC and produce SVC obstruction with prominent 
collateral circulation over the chest.  Diagnosis can be established by 
venous angiocardiography through the jugular vein. 
 
Chronic Pulmonary tuberculosis: 
 Chronic pulmonary tuberculosis is infrequent in younger children.  Children 
above the age of seven years, especially girls are more vulnerable to develop chronic 
pulmonary tuberculosis due to endogenous exacerbation or exogenous super infection.  
During adolescent growth spurt, the metabolic needs are increased and if the 
nutritional intake is not adequate, the resistance of the child is impaired.  Further, 
older children and adolescents are increasingly exposed to diverse sources of infection 
because of increased social contacts. 
 The commonest site of the isolated lesion of chronic pulmonary tuberculosis is 
apex of the lung (Puhl’s lesion), because the blood flow is sluggish at the apex and 
diffusion is poor.  Most of these lesions heal but a few may extend and erode into the 
bronchial lumen causing bronchogenic dissemination.  Infraclavicular lesion of 
chronic pulmonary tuberculosis is called Assman’s focus.  Regional lymph nodes are 
not involved in chronic pulmonary tuberculosis. 
 
Hypersensitivity to tubercular proteins. 
 About 4 to 8 weeks after exposure to the tubercle bacilli, the child develops 
hypersensitivity to tuberculoproteins.  This can be demonstrated by a variety of 
tuberculin tests viz., Mantoux test, Heaf  of Tine test.  Mantoux test is the most 
commonly employed technique.  Tuberculin is injected intradermally and positive 
reaction is indicated by erythema and induration after 48-72 hours.  It is described in 
detail in the section on diagnosis of tuberculosis. 
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CLINICAL FEATURES: 
Incubation Period: 
 The incubation period varies between 4 and 8 weeks.  The clinical features 
usually start with the development of hypersensitivity to tubercular proteins. 
Onset: 
 The onset is generally insidious but may be relatively sudden in cases of 
tuberculous meningitis or military tuberculosis. 
Early Symptoms: 
 The early clinical features of tuberculosis are value and non – descript.  The 
presenting features depend on the severity of infection and resistance of the host. 
 Over two-thirds of the children with primary complex are asymptomatic or 
they may have a mild transient illness which passes off unnoticed in a few days.  In 
the remaining one-third of the patients, the child appears peevish, fretful and off-
colour.  He loses interest in play and is fatigued easily.  His activity is reduced and 
growth is slowed.  There may be no weight gain. 
 
 Evidence of toxemia: 
 The fever is generally low grade but may be high and hectic.  The pulse rate is 
increased.  The appetite is reduced and there is progressive loss of weight.  Night 
sweats especially on the forehead are frequent and the  child looks pale and ill. 
 
SYMPTOMS AND SIGNS DUE TO LOCAL LESIONS. 
 Primary complex.  The primary complex has few localizing symptoms or 
signs.  The cough is an inconstant symptom and may be absent even in the advanced 
disease.  Bronchial and tracheal compression due to enlarged lymph nodes causes dry 
cough, which may quite troublesome. 
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Primary complex with segmental collapse: 
 Segmental atelectasis secondary to bronchial compression is sometimes 
termed epituberculosis.  These patients often have a hectic temperature with drug 
cough and occasional wheezing.  Long standing atelectasis predisposes to 
bronchiectatic changes. 
Progressive primary complex and caseous bronchopneumonia: 
 The child is very sick and toxemic.  There is high fever with general 
malaise.  The cough is often productive.  The physical signs of consolidation or 
cavitation depend on the extent of the lesion. 
Endobronchial tuberculosis: 
 These patients have fever and troublesome cough with or without 
expectoration.  Dyspnea, cyanosis and wheezing may be present.  Obstruction by the 
enlarged lymph nodes pressing the bronchus from outside or the granulomatous tissue 
inside the bronchial lumen causing a partial occlusion of the bronchus may result in a 
ball valve type effect.  This may lead to trapping of inspired air and obstructive 
emphysema in the segment of the long distal to the site of compression.  Complete 
obstruction of the bronchus causes atelectasis of the distal pulmonary segment. 
 
Pleural effusion: 
 A significant proportion of the cases with pleural effusion is tuberculous in 
etiology.  The rest may be due to emphysema; a small proportion is secondary to 
thoracic lymphoreticular malignancies.  Pleural effusion is not common in children, 
and less the 10 percent of tuberculous children develop pleural effusion. 
 The pleura may be infected by hematogenous spread from the primary 
focus.  The subpleural tuberculous focus may extend to the pleural surface.  The 
effusion has also been attributed to allergic response to the tubercular proteins. 
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 Clinically the onset is subacute with high fever, cough, discomfort and pain 
on the affected side of the chest.  The pain becomes worse with deep breathing and 
coughing.  Some patients with basal pleurisy may present with reflex pain in the 
abdomen.  On physical examination, the affected side of the chest is less mobile, the 
intercostal spaces appear full, the mediastinum is shifted to the opposite side, vocal 
femitus is decreased, percussion note is stony dull with a relatively higher level of 
dull note in the axilla (Ellis’ curve).  The breath sounds are distant, vocal resonance is 
decreased and egophony is elicited above the level of effusion. 
 
Miliary tuberculosis: 
 The miliary tuberculosis in children usually cocurs within a year of the 
primary infection.  The onset of the illness is sudden and may present in one of the 
following manners; 
a. Pulmonary type: 
 There is profound toxemia with moderate elevation of temperature, dyspnea 
and cyanosis. There are few clinical signs in the lungs.  Some patients show fine 
crepitating, occasional rhonchi with features of obstructive emphysema.   These 
features may simulate acute bronchiolitis in infancy. 
b. Septicemic type: 
 The illness is severe and the occurrence is fulminant.  The high fever may 
or may not be associated with rigors.  The child is delirious and there may be 
disturbances of sensorium.  The illness resembles septicemia or a severe case of 
typhoid. 
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c. Meningitic type: 
 The child appears peevish and irritable, he vomits frequently and has 
photophobia.  He picks at bed clothes and has shrill cry.  Convulsions occur early 
and there may be a variety of neurological deficits. 
 
DIAGNOSIS OF TUBERCULOSIS: 
 The diagnosis of tuberculosis is based on clinical features, history of 
contact with an open infective case, demonstration of hypersensitivity to 
tuberculin, evidence of radiological lesions suggestive of tuberculosis, and certain 
laboratory investigation.  The latter include demonstration of tubercle bacilli in the 
sputum, gastric lavage or bronchial aspirate, by examination of smear culture for 
acid- fast bacilli and animal inoculation.  The histological appearance suggestive 
of tuberculosis in the diseased viscera is another useful aid for diagnosis. 
 
Clinical features: 
 The clinical features of tuberculosis are vague and non-descriptive.  The 
onset of the illness is subacute and course is prolonged with tendency for periodic 
quiescence and exacerbations. Symptoms suggestive of tuberculosis include fever 
for more than weeks, recent loss of appetite and weight or failure to thrive.  
Children who do not thrive well despite apparently adequate dietary intake and 
those with recurrent respiratory infections should be investigated for tuberculosis. 
Other risk factors favouring diagnosis are age <1 year, recent history of measles / 
whooping cough, Grade III/IV malnutrition, and steroid therapy.  Significant 
lymphadenopathy (inguinal > 1.5 cm; other .1cm) is present in 40-50% cases. 
 Non response to an adequate trial of appropriate antibiotics in a 
symptomatic child also points to possibility of tuberculosis. 
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History of contact with an Infective Case: 
 Contact is defined as any child who lives in a household with an adult 
taking antitubercular therapy or has taken such therapy in past 2years.  History of 
contact is available in less than one-third of the patients.  Contacts can often be traced 
to maidservant, cook, domestic aid or gardener in case of tuberculous children from 
well-to-do families with healthy parents.  Tracing of contact is important not only for 
confirming the diagnosis but also for protection of other vulnerable children from the 
disease. 
 
Tubercullin Test: 
 The tuberculin test is a useful diagnostic aid.  Most frequently used tests are 
Mantoux test and multiple puncture tests. 
 
Mantoux reaction: 
 0.1mL of a suitable dilution of tuberculin (PPD or OT) is injected 
intradermal on volar aspect of the forearm.  Standard dose is 5 TU (equivalent to 1 
TU PPD with RT 23 Tween 80).  A weal of 5mm should be raised.  The  reaction is 
read after 48 hours to 72 hours.  The dosage of tuberculin is measured in tuberculin 
units.  Five tuberculin units are contained in 0.0001mg of purified protein derivative 
(PPD) in 01mL of diluent.  Antigen should not be drawn into the syringe more than 
one hour before use.  The PPD is obtained by culturing Mycobacterium tuberculosis 
H37 RA strain with Tween 80 on a  synthetic protein free medium Quinosol. 
 An induration of more than 10 mm is suggestive of natural infection.  
Nature infection under 2 years of age is suggestive of recent infection and should be 
treated.  In children older than 2 years, natural; infection in association with history of 
contact or symptom / signs or presence of risk factors has higher disease probability. 
 A negative tuberculin reaction does not rule out tuberculosis. 
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 Tuberculin test in the vaccinated children.  Children vaccinated previously 
with BCG show positive tuberculin reaction during infancy.  In older children the 
interpretation of tuberculin test is not altered by the BCG status of the child. 
 
False negative tuberculin reaction: 
 A negative tuberculin reaction in a proven case of tuberculosis may be 
due to one of the following factors: 
1. Test done in the incubation period of tuberculosis or before the 
hypersensitivity has developed. 
2. The tuberculin reaction remains negative for several weeks following 
measles. 
3. During corticosteroid therapy. 
4. Overwhelming infection with tuberculosis e.g., tuberculous meningitis or 
miliary tuberculosis. 
5. Severe malnutrition depresses the hypersensitivity. 
6. Wrong technique.  The infection might have been given subcutaneously 
instead of intradermal. 
7. Inactive tuberculin.  This may due to (a) exposure of tuberculin to sunlight; 
(b) high temperature; or (c) storage for prolonged period after dilution. 
 
BCG Test: 
 During mass BCG vaccination campaign in India, an acceleratd response after 
injection of the vaccine was observed in individuals suffering from tuberculosis.  An 
induration of more than 5-6 mm after 3 days of BCG vaccine is considered a positive 
reaction.  Indian Academy of Pediatrics does not recommend BCG test for diagnosis 
of tuberculosis. 
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Laboratory investigation 
Routine Blood Investigation 
Tc, Dc, ESR, Hb. 
 
Erythrocyte Sedimentation rate (ESR) and blood counts have no value in diagnosis 
or follow up of tuberculosis. 
 
Demonstration of acid-fast bacilli: 
 Most children do not expectorate out the sputum but swallow it.  Therefore the 
sputum is not available for examination.  A laryngeal swab may be obtained for smear 
and culture examination for mycobacteria.  It is customary to examine the gastric 
lavage in children for bacteriological examination on 3 consecutive days.  Ryle’s tube 
is passed in empty stomach, early in the morning before the child has been given any 
breakfast.  The gastric contents are aspirated and sent for bacteriological examination.  
Adding vancomycin to the sample improves the yield of Mycobacterium.  The 
cerebrospinal fluid, pleural or bronchial aspirate, urine and discharges from 
tuberculous sinuses are examined for the tubercle bacilli. 
Histopathology: 
 Glands, liver and other tissues may be examined for histological evidence of 
tuberculosis by fine needle aspiration cytology (FNAC) 
Serology: 
 Antibody detection by ELISA or other methods is of no utility in diagnosis of 
childhood tuberculosis. 
PCR: 
 Sensitivity and specificity of PCR for CSF and pleural fluid is high and that for 
gastric aspirate is low 
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Radiology: 
 Chest X-ray upright PA view is usually sufficient.  CT scan of chest is not 
routinely required,.  Diagnosis of tuberculosis should be strongly considered, if any of 
the following lesions is associated with relevant clinical findings. 
(i) Military mottling; 
(ii) Unilateral pleural effusion; 
(iii) Fibrocaseous cavitatory lesions; and 
(iv) Mediastinal adenopathy with pneumonia. 
 Interestingly, clinical and radiological findings do not match in most 
of tubercular lesions; i.e. radiological findings are in much excess of what a physical 
examination of chest would suggest.  For example, in a child with extensive military 
mottling in the X-ray, clinical examination of the chest may be entirely normal or may 
reveal few fine crepitations. 
 Ultrasonography is useful in detection of enlarged lymph node or 
peritoneal fluid in suspected abdominal tuberculosis. 
 
PREVALENCE: 
 25 percent of children below the age of six and 40 percent of children below 
the age of 12 in the lower socio economic group have already contracted the infection.  
The magnitude of the problem in the community is directly related to the prevalence 
of the disease among the adults and the facilities or the lack of them for the isolation 
of the ‘open’ adult cases. 
 According to the WHO, there are approximately 15 million people suffering 
from active tuberculosis of which three million people succumb every year.  In India 
alone, there are  8-10 million radiologically positive cases out of which 2.5 – 3 
million are infectious with a mortality  of half a million every year. 
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Socio economic factors: 
 A higher tuberculous infection rate was observed in children from the lower 
socio-economic group living in overcrowded localities.  This is perhaps due not only 
to poor living conditions but also to the polluted environment.  It was noted that adult 
tuberculosis was rampant here and as many as 44 percent of children below six years 
and 83 percent between 7 and 14 were positive reactors . 
Evolution: 
 Tuberculosis is produced by the entry of the tubercle bacilli into the body when 
the host factors are favorable for its development.  In children as well as in adults, the 
common mode of entry is by inhalation (lungs).  Occassionally, they may gain 
entrance through the alimentary tract by ingestion or rarely by inoculation through 
abraded skin, conjunctiva or external genitalia.  The available bacteriological 
evidence points to a human type of bacillus as the cause of the disease both in human 
beings and animals.  Bovine tubercle is rarely isolated from culture in cattle.  The 
sources of infection as far as children are concerned are adults with ‘open’ 
tuberculosis.  In the younger child, it is often a family member or a neighbour.   
However, it is more difficult to trace the contact in older children as by this time they 
might have come into contact with a large number of people in the locality or school. 
Precipitating factor: 
 After inhalation of the tubercle bacilli the active disease is not always 
produced.  Several factors operate in converting infection into disease.  These are age, 
sex, virulence and dose of bacilli, environment, resistance and allergy. 
 Age: The younger the child, the greater the risk of the disease manifesting after 
infection.  Again, in adolescence and early adult life, the risk of a reactivated flare up 
is greater than later on or in the school – going period. 
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 Sex: This is not a significant factor till adolescence during which both 
mortality and morbidity appear to be higher in girls. 
 Dose of bacilli: Repeated heavy doses are likely to result in active disease.  
Intimacy of contact with an open case and frequency of exposure, e.g., an infant who 
is being cared for by an infected parent or grandparent, are more significant. 
 Lowered resistance is found 1) after meals and whooping cough, 2) in protein 
calorie malnutrition, 3) in poor living standards, e.g. overcrowded, lack of fresh air 
and sunlight per se will not cause tuberculosis but favour infection and activity when 
there is an open case in the house, and 4) in communities not exposed previously to 
tuberculosis, e.g. Fijians in Fiji are more prone to active disease than Indians settle in 
Fiji. 
 Virulence of bacilli: Studies show that the Indian tubercle bacilli have the 
lowest virulence to the guinea pig.  The British strains show high virulence, while the 
Thai strains occupy intermediate virulence 
 Allergy: After the entry of the tubercle bacilli in to the system allergic 
manifestions (positive tuberculin test, erythema nodosum, phylectenular conjunctivitis 
and epituberculosis) occur after a variable period (2-8 weeks; average six weeks).  
The clinical features appear to depend upon the presence of these allergic phenomena 
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MATERIALS AND METHODS 
 
I    BACKGROUND 
 
Kanam is a common problem all over the world and specifically, it is common 
in childhood.  
“we<eOu!g{!&e<X!uVmf<!okim<Om!
! Wpi{<M!lm<Mg<G!lqVg<Gr<!gizl<” 
!
“JbK!%cx<oxe<xiz<!niqjubI!Kbvf<ke<eiz<!
! osb<b!hx<!HezVf<kq!osxq!sz!Okimf<!ke<eiz<!
! jhbv!uz<GziTl<!hsqBmeqVf<kkiZl<!
! Kb<b!OkiI!Gpuq!gm<G!g{r<gTf<!Okie<X!le<Ox!” 
 
In Balavakadam text, there is a preparation named Madulai nei. In text book of 
Materia medica (Mooligai),Madhulai juice has been indicated specially for Kanam. In 
this preparation Tinospora cordifolia has been added in the form of Sennthil sarkarai  
which is a good immune-modulator. This drug has been recommended for 18 types of 
Kanam in Siddha literature. It is proposed to estimate the efficacy of this drug in an 
open clinical trial. 
 
II    AIMS 
 
      a)  Primary Aim 
 
   To estimate the efficacy of Madhulai Nei in the treatment of Kanam 
 
       b) Secondary Aim 
 
 To find out the side - effects of the drug, if any. 
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III     POPULATION AND SAMPLE 
 
      The population consists of pediatric patients with Respiratory tract infection 
satisfying the inclusion and exclusion criteria mentioned below. The sample consists 
of patients attending the Ayothidoss Pandithar Hospital of the National Institute of 
Siddha, Chennai-47. 
 
IV    SAMPLE SIZE 
  The trial size will be 30 patients. 
 
V    INCLUSION CRITERIA 
           1. Aged 3 to 7 years 
2. Duration of disease not more than 2 years 
3. Willing to give blood specimen for the investigation when required 
4. Willing to attend OPD once in 7 days 
 
VI    EXCLUSION CRITERIA 
1. Jaundice  
2. Congenital heart diseases 
3. Neurological manifestations  
4. Any other serious illnesses 
 
VII    WITH DRAWL CRITERIA 
1. Exacerbation of symptoms 
 
2. Occurrence of any other serious illness 
 
VIII    TRIAL DRUG AND DURATION 
 
    Madualai nei  3 to 4 years  -   4 ml b.d.  after food. 
          5 to 7 years   -  8 ml b.d.  after food. 
 
    Trial treatment period :  41 days. 
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IX    TESTS AND ASSESSMENTS: 
a) Clinical Assessments 
 
 Cough, Cough with expectoration. Wheezing, Nasal catarrh, 
 Stuffy nose, Grunting sound, Loss of appetite, Fever, Abdominal pain, 
Passing loose stools  
                                        
b)  Siddha Assessments 
                   Nilam, Kaalam, Uyir thaathukkal, Udal thaathukkal,  
        Envagai thervugal 
            c)  Investigations 
                  Blood Test: TC, DC, Hb, ESR and RBC count, Sputum for AFB, chest x-ray.  
           d) Siddha Investigations 
 
                 Neerkuri, Neikuri 
X    CONDUCT 
 
Kanam patients satisfying inclusion and exclusion criteria will be admitted to 
the trial. Informed consent will be obtained from the parents. Investigations will be 
carried out before treatment and at the end of the treatment. 
The trial drug will be issued to the patients for 7 days at a time. Patients will be 
asked to come for clinical assessment once in 7 days.Also, they will be asked to bring 
back unconsumed drug at each visit and return them. At each visit, a new drug 
container will be issued to the patients. 
 
XI      FORMS 
            Form I - Selection proforma-Used before admission to the trial.  
              Form II - Assessment proforma-Used weekly during treatment. 
XII       ANALYSIS 
 Paired X² -test for the before and after treatment difference in    proportions 
and Paired t- test for the before and after treatment difference in means will be used. 
 56
RESULTS AND OBSERVATION 
 
Results were observed with respect to the following criteria 
 
1. Age 
2. Sex 
3. Parents Occupation 
4. Food habits 
5. Parents Socio- economic  status 
6. Thinai 
7. Paruvakaalam 
8. Yaakai 
9. Gunam 
10. Iymporigal 
11. Kanmendhirium 
12. Vali 
13. Azhal (Pitham) 
14. Iyyam (Kabam) 
15. Ezhu udal thaathukkal 
16. Envagai Thervugal 
17. Malam 
18. Moothiram 
19. Neikuri 
20. Naadi 
21. Clinical Features 
22. Haemetological Profile 
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23. Bio chemical Analysis 
 
24. Anti Microbial Activities 
 
25. Pharmacological Activities 
 
26. Results  
 
 
 
Table : 1.   Age among the patients with kanam. 
 
        Age (Year) Number of Patients         Percentage (%) 
4                     4 11.4 
5                     8 22.9 
6                     8 22.9 
7 15 42.9 
 35 100.0 
 
 
 
No. of Patient
11.4
22.9
22.9
42.9
4 5 6 7
 
 
 
 
Inference : About 50% of them were aged 7-8 years (Table 1) 
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Table : 2.  Gender Distribution 
 
Incidence of sex among the patients with kanam: 
 
 
 
 Number of 
Patients 
Percentage 
Male Children 14 40.0 
Female Children 21 60.0 
Total 35 100.0 
 
 
Inference:  Out of 35 patients 60% were female children. (Table 2) 
 
 
 
 
Table 3.  Distribution of patients with kanam according their parents occupation 
 
 
 
Father’s Occupation       No of patients            Percentage 
1.Farmer 17 49 
2.Driver 9 25.7 
3.Unskilled labor 7 20.0 
4.Teacher 1 2.9 
5.Bussiness 1 2.3 
Total 3 100 
 
 
 Inference : The most of the parents were farmer (49%) (Table 3) 
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Table 4.  Food habits of Patients with kanam 
 
Food Habits No of Patients Percentage 
1.Vegetarian 5 14.3 
2.Non Vegetarian 30 85.7 
 Total 35 100 
 
 
14.3
85.7
Vegetarian
Mixed
 
 
 
Inference :  
 
According to food habits 86% of cases have mixed diet and 14% had 
vegetarian diet (Table 4) 
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Table 5. Socio economic status of patients with kanam 
 
 
  Socio economic status             No of  Patients            Percentage 
1.Lower Income Groups                     22                  62.9 
2. Middle Income Group                     13                  37.1 
3. High Income Groups - 0 
Total                     35                   100 
 
 
 
0
20
40
60
80
1.LIG 2.MIC 3.HIG
           Percentage
1.LIG
2.MIC
3.HIG
 
 
 
 
Inference:   
 
About two thirds (63%) of the parents were farmer (Lower Income Group) 
(Table 5) 
 
 
 
 
 
 
 
 
 
 
 
 
 61
 
Table 6. Distribution of patients with kanam according to Thinai. 
 
 
Thinai No. of Patients           Percentage (%) 
1.Kurinji                      03 8.5 
2.Mullai 17 48.5 
3.Marutham 07 20.0 
4.Neithal 08 22.8 
5.Palai -  
 
 
 
Percentage
8.5
48.520
22.8 0 Kurinji
Mullai
Marutham
Neithal
Palai
 
 
 
Inference :  
 
According to thinai, the highest distribution (49%) was noted in Mullai, In 
Neithal 22%, In Maruthan 20% and Kurunji 9% was observed (Table 6). 
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Table 7. Distribution of patients with kanam according to paruvakaalam. 
 
 
Paruvakaalam No. of Patients Percentage (%) 
1. Kaarkaalam 21 60.0 
2. Koothir kaalam 33 94.2 
3. Munpani kaalam 12 34.2 
4. Pinpani kaalam 8 22.8 
5. Illavenil kaalam 14 40.0 
6. Muduvanil kaalam 18 51.4 
 
 
Percentage
60
94
34
22.8
40
51
0
20
40
60
80
100
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Pinpanikaalam Illavenirkaalam Muduvenirkaalam
 
 
 
Inference: 
 
According to paruvakaalam, the highest incidence (94%) was noted in koothir 
kaalam, in kaar kaalam 60%, In muduvanil kaalam 51%, In Illavenil kaalam40%, In 
Munpani kaalam34% and Pinpani kaalam 23%cases were noted (Table 7) 
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Table : 8. Distribution of patients with kanam according to Yaakai 
 
Yaakai Number of Patients Percentage 
1.Vatham 11 31.43 
2. Vatha Pitham 11 31.43 
3. Vatha kabam 3 8.57 
4. Pitham 5 14.29 
5.Pitha vatham 1 2.86 
6. Pitha kabam - - 
7. Kabam 4 11.43 
8. Kaba vatham 0 0 
9. Kaba Pitham 0 0 
 
 
Percentage
31.43
31.43
8.57
14.29
2.86
0
11.43 0
0
Vatham
Vatha Pitham
Vatha Kabam
Pitham
Pitha Vatham
Pitha Kabam
Kabam
Kaba Vatham
Kaba Pitham
 
 
 
Inference:  
Vatham and Vatha Pitha Yaakai was observed in 31% of patients, Pitha Yaakai was observed 
in 14% of cases, Kaba Yaakai was noted in 11% of cases, Vatha Kaba Yaakai was noted in 
9% of cases, finally 3% of patients observed in Pitha Vatham (table –8) 
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Table – 9. Distribution of patients with kanam according to Gunam 
 
 
Gunam             No. of Patients           Percentage (%) 
1. Sathuvam - - 
2. Rasatham 30 85.71 
3. Thamasam 05 14.29 
 
 
 
Percentage
0
85.7
14.3
Sathuvam
Rasatham
Thamasam
 
 
 
Inference: 
 
According to Gunam, the highest distribution (86%)was noted in Rasatham 
and Thamasam was noted 5% of cases (Table 9). 
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Table : 10  Alteration in Iymporigal 
 
Iymporigal Number of Patients Percentage (%) 
1.Mei 11 31.43 
2.Vaai 12 34.29 
3.Kan 7 20.00 
4.Mooku 33 94.29 
5.Sevi - - 
 
 
Percentage
31.43 34.29
20
94.29
0
0
20
40
60
80
100
Mei Vaai Kan Mooku Sevi
Mei Vaai Kan Mooku Sevi
3
 
 
Inference: 
In Iymporigal, Mooku was affected in 94% of cases, Vaai was affected in 34% 
of cases, Mei was affected in 31% of cases, Kan was affected in 20% of cases.  
(table –10) 
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Table :11. Alteration in Kanmendhirium 
 
Kanmendhirium Number of Patients Percentage (%) 
1.Kai 0 0 
2.Kaal 0 0 
3.Vaai 18 51.43 
4.Eruvaai 25 71.43 
5.Karuvaai 0 0 
 
 
Percentage
0 0
51.43
71.57
0
0
20
40
60
80
Kai Kaal Vaai Eruvaai Karuvaai
 
 
 
Inference:  
 
According to Kanmendhirium, Vaai was affected in 51% of cases, Eruvai was 
affected in 71% of cases (table –11) 
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Table 12.  Distribution of patients with kanam according to Vali (Vatham) 
 
Alteration in Vali: 
Types Of Vali No Of Patients Percentage (%) 
1.Pranan(Uyir kaal) 35                     100 
2.Abanan(Kezhnokku kaal) 30 85.71 
3.Viyanan(Paravu kaal) 32 91.43 
4.Uthanan(Melnokku kaal) 3 8.57 
5.Samanan(Nadu kaal) 30 85.71 
6.Nagan 5 14.29 
7.Koorman 4 11.43 
8.Kirukaran 33 94.29 
9. Devathatan 4 11.43 
10.Dananjeyan - - 
 
Percentage
100
85.7
91.4
8.5
85.7
14.2 11.4
94.2
11.4
0
20
40
60
80
100
120
Pranan Abanan Viyanan Ut hanan Samanan Nagan Koorman Kirukaran Devat hat han Danajeyan
Pranan Abanan Viyanan Uthanan Samanan
Nagan Koorman Kirukaran Devathathan Danajeyan
 
 
Inference :  
 
According to vali, derangement of pranan was 100%,Viyanan was91%, 
Abanan ,Samanan was deranged in 85%, and Kirukaran was 94%. (Table 12) 
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Table 13: Distribution of patients with kanam according to Azhal (Pitham) 
 
Types Of Azhal No Of Patients Percentage (%) 
Analagam (Aakanal)                     33                   94.2 
Ranjagam (Vannaerri) 29 82.6 
Sathagam (Aatralangi ) 24 68.5 
Alosagam (Nokkanal) 5 14.2 
Prasagam (Oollolithee) 4 11.4 
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Inference:  
 
According the Azhal, Analagam was affected in 94% cases, Ranjagam was 
affected in 83% cases, Sathagam was affected in 69%, Alosagam was affected in 14% 
and Prasagam observed in 11%. (Table 13) 
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Table .14. Alteratin in Iyyam: 
 
Types Of  Iyyam      No Of Patients           Percentage (%) 
Avalambagam (Alliyyam)                 32                 91.43 
Klethagam (Neerpiyyam) 31 88.57 
Pothagam (Suvaikanaiyyam) 20 57.14 
Tharpagam (Niraivaiyyam) 7 20.00 
Santhigam (Oondriyyam) - - 
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Inference :  
According to Iyyam, Avalambagam was deranged in 91% of cases. Klethagam 
iyyam was affected in 89% of cases. Pothagam was deranged in 57% of cases.  
Tharpagam was affected in 20% of cases (Table 14). 
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Table : 15. Ezhu udal thaathukkal of patients with kanam 
 
Udal thaathukkal No of Patients Percentage (%) 
Saaram   35 100 
Senneer  18 51.43 
Oon  09 25.7 
Kozhuppu 03 8.57 
Enbu    03 8.57 
Moolai      0 0 
Sukkilam 0 0 
Suronitham 0 0 
  
Percentage
100
51.43
25.7
8.57 8.57
0 0 0
0
20
40
60
80
100
120
Saaram Senneer Oon Kozhuppu Enbu Moolai Sukkilam Suronitham
Saaram Senneer Oon Kozhuppu
Enbu Moolai Sukkilam Suronitham
 
 
Inference: 
 
Saram was affected in 100% of cases, senneer was affected in 51% of cases.  
Oon affected in 25% of cases, and enbu, kozhuppu were affected in 9% of cases. 
(Table 15) 
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Table : 16. Envagai thervugal of patients with kanam. 
 
 
Envagai thervugal No. of Patients Percentage 
Naa:a)Coated and slightly dried tongue 
           b) Ulcer in the tongue 
           c) Pallor           
               10 
03 
12 
28.6 
8.6 
34.3 
Niram - - 
Mozhi 05 14.3 
Vizhi: a) Pallor of the conjunctiva 20 57.1 
             b) Muddy conjunctiva 04 11.4 
parisam: Raised temperature 14 40.0 
 
 
Inference: 
Out of 35 cases coated and slightly dried tongues were noted in 29% cases and 
ulceration in the tongue were noted 9% and pallor tongue was noted in 34% of cases. 
 
14% of cases were found pallor conjunctiva and 11% cases were had muddy 
conjunctiva. 
  
40% of cases were noted that body temperatures were in 14 cases. 
        (Table – 16). 
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Table: 17.  Malam of patients with kanam  
 
Thanmai No. of Patients Percentage (%) 
1.Normal 9 25.71 
2.Irugal 13 37.14 
3.Illagal 13 37.14 
 
 
 
 
 
Malam
25.71
37.14
37.14 Normal
Irugal
Illagal
 
 
 
Inference: 
 
According to Malam, Irugal was observed in 37% of patients, Illagal was 
observed in 37% of cases, Normal patient was 26%. (Table 17) 
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Table 18. Moothiram of patients with kanam: 
 
 
Moothiram No. of Patient Percentage (%) 
1.Normal 24 68.57 
2.Enjal 11 31.43 
 
 
 
 
MOOTHIRAM
24
11
Normal
Enjal
 
 
 
Inference: According to Moothiram,Enjal was observed in 31% of cases, Normal 
patient was 69% (table –18) 
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Table. 19.    Neikuri of  patients with kanam: 
 
Neikuri No. of Patients Percentage (%) 
1.Vaatham 9 25.71 
2.Pitham 23 65.71 
3.Kabam 3 8.57 
 
 
Neikuri
25.71
65.71
8.57
Vaatham Pitham Kabam
 
 
 
Inference:   
 
According to Neikuri, Pitham neer was observed in 66% of cases, Vatham neer 
was observed in 26% of cases, Kaba neer was observed in 9% of cases. (Table –19) 
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Table 20. Distribution of Naadi among the patients with kanam. 
 
       Naadi          No Of  Patients              Percentage (%) 
1. Vali Azhal 14 40 
2. Vali Ayyam 2 5.7 
3. Azhal Vali 17 48.5 
4. Azhal Iyaam 0 0 
5. Iyyam Vali 2 5.71 
6. Iyyam Azhal 0 0 
 
 
 
Percentage
40
5.7
48.5
0
5.71
0
Vali Azhal
Vali Ayyam
Azhal Vali
Azhal Iyaam
Iyyam Valli
Iyyam Azhal
 
 
 
 
 
Inference:   
 
Vali Azhal naadi was observed in 40% of patients and Azhal vali naadi was 
observed in 49% of patients (Table 20) 
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Table : 21  Showing the clinical features : 
 
No of patients observed 
in Before treatment 
No of patients observed in 
after treatment 
Cough 34(97.1) 4(11.4) 
Cough &Expectoration 34(97.1) 3(8.6) 
Nasal catarrh 34(97.1) - 
Stuffy Nose 33(94.3) - 
Loss of appetite 30(85.7) 8(22.9) 
Halitosis 4(11.4) - 
Breathlessness 30(85.7) 2(5.7) 
Grunting sound 32(91.4) 7(20.0) 
Wheezing 31(88.6) 8(22.9) 
Fever 14(40.0) - 
Abdominal pain 25(71.4) 2(5.7) 
Scanty Micturition 13(37.1) - 
Thirst  12(34.3) - 
Dryness of tongue 12(34.3) - 
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Inference: 
 
Among the 35 cases 97% of the patients had cough with expectoration, Nasal  
Catarrh, stuffy nose.94% of patients were had loss of appetite.89% of patients had 
Wheezing. 86% of cases had breathlessness.91% of patients had grunting sound. 1% 
of case had abdominal pain.40% of patients had fever.37% of cases had scanty 
micturition.34% of patients had dryness of tongue and thirst. Cough and 
Breathlessness and abdominal pain were relieved in most of the case. (table-21) 
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Table : 22    Hematological profile outpatients with kanam 
S.N
O 
OUT 
PATIENT 
No 
BEFORE TREATMENT AFTER TREATMENT 
TOTL 
WBC 
Cells/ 
cu.mm 
DIFFERENTIAL 
COUNT 
ESR 
(mm) 
½/ 1 hr 
Hb 
G% 
TRBC 
cells/ 
cu.mm 
TOTAL 
WBC 
cells/ 
cu.mm 
DIFFRENTIAL 
COUNT 
ESR 
(mm) 
½ / 1 hr 
HB 
g% 
TRBC 
cells/ 
cu.mm 
   P L E M     P L E M    
1. R2308 8200 40 48 12 - 14/28 9.2 3.6 7800 52 44 04 - 10/20 12.6 3.8 
2. R8339 7800 50 36 14 - 16/32 8.0 2.8 8000 50 40 04 - 06/12 12.0 3.2 
3. R8862 7800 66 32 08 - 04/08 11.4 3.8 8200 78 20 02 - 02/04 12.8 3.2 
4. R8852 7500 52 38 10 - 06/14 11.4 3.9 7300 58 38 04 - 03/06 12.0 3.2 
5. R9984 7800 50 34 16 - 07/16 11.8 3.4 7800 50 48 02 - 03/06 13.0 3.6 
6. S747 6200 42 44 14 - 14/28 9.4 2.8 7000 58 38 04 - 03/06 12.0 3.1 
7. S707 8000 44 44 12 - 12/24 9.0 3.0 8500 55 42 03 - 03/06 13.0 3.2 
8. S1213 7400 54 32 14 - 10/20 11.6 4.0 7500 50 46 04 - 03/06 12.8 4.1 
9. S1144 6300 42 46 12 - 02/04 11.2 3.8 7800 58 40 02 - 02/04 13.0 3.8 
10. S1852 8200 56 40 04 - 12/24 11.2 3.8 8200 58 40 02 - 06/12 12.6 3.9 
11. S1873 8600 54 42 14 - 03/06 10.2 3.5 9000 54 44 02 - 03/06 12.0 3.5 
12. S2483 9200 50 34 14 - 04/10 10.6 3.3 9200 50 40 02 - 03/06 12.6 3.2 
13. T3134 7000 50 40 10 - 11/22 8.6 2.8 7200 50 46 04 - 04/08 10.0 3.0 
14. T3674 8400 48 44 08 - 12/24 12.0 4.1 8400 50 47 03 - 06/12 12.8 4.1 
15. T4363 7500 50 46 04 - 12/24 10.8 3.2 7500 52 46 02 - 04/08 12.0 3.3 
16. T4460 7000 60 30 10 - 09/18 9.6 3.0 7200 64 34 02 - 06/12 12.4 3.1 
17. T4866 7300 50 43 07 - 07/14 10.0 3.4 7500 56 40 04 - 03/06 12.6 3.4 
18. T4945 7000 50 39 11 - 12/24 9.4 3.8 7100 58 40 02 - 04/08 11.4 3.9 
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S.NO 
OUT 
PATIEN
T No 
BEFORE TREATMENT AFTER TREATMENT 
TOTAL 
WBC 
Cells/ 
cu.mm 
DIFFERENTIAL 
COUNT 
ESR 
(mm) 
½ /1 hr 
Hb 
g% 
TRBC 
Cells 
/cu.mm 
TOTAL 
WBC 
Cells/ 
cu.mm 
DIFFRENTIAL 
COUNT 
ESR 
(mm
) 
HB 
g% 
TRBC 
cells/ 
cu.mm 
   P L E M     P L E M    
19.  T4946 7800 50 40 10 - 10/22 11.0 3.9 7800 56 40 04 - 06/12 12.2 3.9 
20.  T5059 7100 58 40 02 - 07/14 11.0 3.0 7100 58 40 07  04/08 12.4 3.1 
21.  T5096 7200 50 38 12 - 16/32 11.6 3.6 7300 58 38 04  05/10 12.8 3.8 
22.  T5401 7400 56 40 04 - 10/20 11.0 3.2 7500 60 38 02  07/14 12.2 3.4 
23.  T8142 6800 52 40 08 - 10/20 9.0 2.8 7000 56 40 04  06/12 11.4 3.0 
24.  T8587 6800 50 42 08 - 10/22 9.8 2.8 6900 52 44 04  06/09 11.0 3.4 
25.  T8653 8600 58 40 02 - 12/24 10.4 3.2 8600 58 40 02  06/12 12.6 3.4 
26.  T9052 8000 48 45 07 - 16/32 12.0 4.0 8000 52 45 03  06/12 13.2 4.0 
27.  T9063 8600 50 38 12 - 17/34 11.8 3.8 8000 64 32 04  12/24 12.8 4.0 
28.  T9313 6800 56 40 04 - 11/22 10.6 2.9 7000 63 34 03  08/16 12.8 3.0 
29.  T9364 7100 50 42 08 - 13/26 10.4 3.0 7200 60 38 02  06/12 11.6 3.2 
30.  T9392 8300 50 40 07 03 14/28 11.0 3.2 8300 60 36 03 01 05/10 12.8 3.3 
31.  U544 7800 54 36 10 - 17/34 11.2 3.6 7500 60 36 04 - 04/08 12.8 3.8 
32.  U534 7800 54 36 10 - 08/16 10.0 3.2 7600 60 36 04  04/08 12.0 3.4 
33.  U1401 8200 57 36 06 - 16/32 11.0 3.2 8000 60 38 02  06/12 12.4 3.4 
34.  U2130 7600 50 42 06 - 15/32 11.2 3.4 7500 60 38 02  10/20 12.6 3.5 
35.  U2496 6700 51 40 04 - 18/36 9.4 2.9 6700 60 38 02  11/22 11.6 3.0 
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22.Haematological profile 
 
 Most of  the cases Hb level was well increased and ESR considerly  
decreased  which shows the marked  relief of the Kanam patients. 
 
 
23. Biochemical analysis 
 
 The Bio chemical analysis of trial medicine showed the presence of calcium 
and ferrous iron.   
 
 24. Antimicrobial Activity 
 
Antimicrobial activities of the Madhulai Nei significantly inhibited the 
growth of the bacterial strains against Staphylococcus, Streptococcus, 
Escherichia coli, Pneumococcus, Klebsiella and Proteus. 
 
25. Pharmacological analysis 
 
The trial drug has significant anti pyretic, analgesic,  acute anti 
inflammatory and anti diarrheal activity. 
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26. Results 
S.No Result No. of Patients Percentage 
1. Cured 24 68 
2. Improved 9 26 
3. No changes 2 6 
 Total 35 100 
 
68
26
6
Cured Improved No changes
 
 
 
Inference: 
 Out of 35 patients 24 (68%) were cured, 9(26%) cases were improved and 
no changes in 2 (6%) patients. (Table-26) 
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DISCUSSION 
 
“Kanam” is a common pediatric problem. This disease is clearly described 
in several siddha texts.  
In this study, thirty-five cases were treated in the out patient department, 
according to clinical features mentioned in siddha texts. Siddha methods of 
diagnosis were carried out and recorded in selection proforma with the help of 
modern investigations. The diagnosis were confirmed and treated with the drug 
“Madhulai nei” and clearly observed. The observations are described here under. 
 
1. Distribution according to age 
 Out of 35 cases 11% of patients were under 4 years, 23% of patients came 
from under 5 years, 23% of patients were from 6 years and remaining 43% of 
patients were under age group of 7 years. 
 
2. Distribution according to sex 
 Among 35 cases 14(40%) were males and 21(60%) were female children. 
 
3. Distribution according to food habits 
  According to this study 86% of cases were mixed diet and 14% were  
vegetarian diet. 
 
4. Distribution according to socio-economic status 
 Most of the patients (63%) belonged to poor socio-economic status.37% of  
Patients belonged to middle class. Parents occupation and socio-economic status 
may be the reason why these patients were predisposed to develop kanam. 
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5. Distribution according to parents’ occupation 
 Out of 35 cases, 49% of patient’s parents were former.26% of patient’s 
parent were unskilled workers. This higher Distribution may be, due to lack of 
knowledge in personal hygiene and socio-economic status. 
 
6. Distribution according to Thinai 
According to thinai, the highest Distribution (49%) was noted in Mullai, in 
Neithal 22%, In Marutham 20% and Kurunji 9% was noted. In Siddha literature 
Mullai is the  source of pitha and vatha diseases. Neithal is the source of pitha 
diseases and kaba diseases. Majority of cases came from Mullai and neithal. This 
may be due to altered life style and environment. More over the high degree of 
temperature in Chennai and its surrounding areas may be responsible for 
increasing pitham and therefore results kanam. 
 
7. Distribution according to paruva kaalam 
According to paruvakaalam, the highest Distribution (94%) was noted in 
koothir kaalam, in kaarkaalam 60%, in muduvanil kaalam 51%, in illavenil kaalam 
40%, in munpani kaalam 34% and pinpani kaalam 23%cases was noted. In koothir 
kaalam pitham changed from thannillai to piranillai valarchi due to chillness. The 
unexpected heavy rain at the end of the munpani kaalam(end of the Thai) may be 
predisposed to develop kanam in these paruva kaalankal. 
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8. Yaakai 
 According to Yaakai, the high Distribution was noted in vatham and vatha 
pitha Yaakai In siddha literature character of vatha Yaakai is poor appetite, 
increased flatulence, and pain. Character of vatha pitha Yaakai is lean and blackish 
colour. Character of pitha Yaakai is dryness of body, whitish, poor intake of food. 
 
9. Distribution according to Gunam  
 
According to Gunam 86% of cases rasatha gunam 
 
10. Distribution according to Iymporigal  
 
According to iymporigal 94% of cases were affected Mooku, (nasal Catarrh, 
stuffy nose, sneezing) 
 
11. Distribution according to kanmendhirium 
 
According to kanmendhirium 71% of cases affected eruvai (passing loose 
stools , constipation.) 
 
12. Vali (Vatham) 
 All the 35 cases showed derangement of Uyir kaal (Piranan) due to 
breathlessness, Cough with expectoration, wheezing, grunting sound.91% cases 
Showed derangement of Paravu kaal (Viyanan) that produced loss of appetite, 
Abdominal pain . Kirukaran was deranged in 94%cases, which produced cough 
Kezhnokku kaal (Abanan) and Nadu kaal(Samanan) was deranged in 86%case, 
which produced constipation, loose stools,  abdominal pain. Melnokku kaal 
(Uthanan) was deranged in 9% of cases, which produced loss of appetite, nausea, 
vomiting. Nagan was deranged in 14% of cases, which produced redness of eyes. 
Devathatan was deranged in 11% of cases which produced sleeplessness. 
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13. Azhal (Pitham) 
94% of patient showed derangement of Aakanal (Analagam) which 
produced poor appetite, constipation and loose stools.  Pallor of the skin may be 
caused by the affection of Oollolithee (Pirasaka pitham) and Vannaerri (Ranjaga 
pitham). 
14. Iyyam (Kabam) 
 Deranged Alliyyam (avalambagam) and Neerpiyyam (Klethagam) in all 
cases produced poor appetite, loose stools and constipation. 
 
15. Distribution according to ezhu udarkattugal 
In this Saram, senneer, Oon, kozhuppu, enbu, moolai, were affected, which 
produced symptoms like loss of appetite, anemia, gradual reduction in weight and 
emaciation of the body. 
 
16. Envagai thervugal 
 According to this study naa was affected in 71% of cases (coated, 
ulceration and pallor) vizhi were affected in 71% of cases (pallor), parisam was 
affected in 40% of cases (raised temperature) 
 
17. Malakuri 
 According to malakuri, 37% of cases had Irugal (constipation) and 37% of 
cases had illagal (passing loose stools).In siddha literature, Irugal and illegal is due  
to alteration in vatham and pitham. 
 
18. Neerkuri 
According to neerkuri, 31% of patients had affected in enjal (scanty 
micturition), this due to increased Pitham. 
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19. Neikuri 
In this study, most of patients had pitha neer.  Kanam is mostly due to 
increase of  pitham, so this Neikuri indicates pitha neer. 
 
20. Naadi 
According to naadi, high Distribution observed in vali Azhal, iyyam vali 
and iyyam Azhal naadi. In siddha literature, the character of vali Azhal is mainly 
constipation, poor appetite, abdominal pain, indigestion, nausea and vomiting then 
the character of iyyam vali is mainly vomiting, cough, wheezing and iyyam Azhal 
naadi was mainly fever, cough, wheezing, vomiting, anemia, diarrhoea.  
 
21. Distribution according to clinical presentation 
 Among the 35 cases 97% of the patients had cough with expectoration, 
Nasal Catarrh, stuffy nose.94% of patients were had loss of appetite.89% of patients had 
Wheezing. 86% of cases had breathlessness.91% of patients had grunting sound. 1% of 
case had abdominal pain.40% of patients had fever.37% of cases had scanty 
micturition.34% of patients had dryness of tongue and thrist. The clinical improvements 
were accurately noted and further follow up was made in out patient department. 
 
22. Laboratory investigations 
Most of cases were had increased lympocytosis, Increased ESR, Reduced 
hemoglobin level. Sputum for AFB was negative for all cases. 
 
23. Biochemical analysis 
 The Bio chemical analysis of trial medicine showed the presence of calcium 
and ferrous iron.  Ferrous iron is more soluble and therefore more readily 
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absorbed. Calcium is essential for growth, as it plays an important role in the 
formation of bones and development of teeth. Also calcium is necessary for 
coagulation of blood and also necessary for the clotting and digestion of milk. 
 
24. Antimicrobial activitiy 
Antimicrobial activities of the Madhulai Nei significantly inhibited the 
growth of the bacterial strains against Staphylococcus, Streptococcus, Escherichia 
coli, Pneumococcus, Klebsiella and Proteus. 
 
25. Pharmacological analysis 
The trial drug has significant anti pyretic, analgesic, and acute anti 
inflammatory and anti Diarrheal activity.  Antipyretic action of the Madhulai Nei 
helps hyperpyrexia kanam patients. Analgesic action of the drug  helps in relieving 
abdominal pain. Anti  inflammatory action reduces the inflammation and anti 
diarrhoeal activity of the drug helps to reduces bowel movements. 
 
 
26. Result 
The trial medicine chosen for treatment of kanam was “Madhulai Nei”.  
The ingredients of this drug have property of controlling kanam. Action of 
madhulai has Astringent, Stomachic, Antihelmimtic, and Refrigerant. Character of 
astringent is blood purifier (increases hemoglobin level) and reduced diarrhea and 
neutralize pitham. kanam in mainly pitha disease. So madhulai juice neutralize 
pitham.Stomachic action promoting appetite.antihelmentic action reduces worms. 
refrigerant action reduces fever. 
 
Seenthil has mainly Alternative, antiperiodic, Demulcent, Stimulant, 
Stomachic, Tonic, Mild diuretic actions. Alternative action is useful for promoting 
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body weight, Anti periodic action is useful for reducing fever and pitham. 
Demulcent action is also helpful for reducing pitham. Tonic action promotes 
appetite. Mild diuretic is useful for neer churukku (Burning micturation and scanty 
micturation). 
 
 Sathikkai has Stimulant, Carminative, Tonic actions. These actions are very 
useful for Promoting appetite and increase body weight and digestion. 
  
Sathi-pathiri has Carminative, Stimulant and Hypnotic actions. Hypnotic 
action is very useful for sleeplessness cases. 
  
Elam has Stimulant, Carminative, Stomachic actions. It is useful for 
reducing pitham and promoting appetite. 
  
Cows butter has Demulcent, Tonic actions. These actions are useful for 
reducing pitham. 
 
All the patients were strictly advised to follow pathiyam. High nutritional 
diet which helps to control the disease and is also advised to the patient. They 
were also advised to follow personal hygiene and other preventive measures 
karpoorathi oil was applied over chest every night, purpose of expelling sputum 
next day morning.  Satisfactory improvement was reported in 7 days of 
commencement of the treatment. Out of the 35 cases signs and symptoms were 
relived in 69% of cases. Symptoms and signs were reduced in 26% of cases. No 
changes occurred in 6% of cases. These results were based on the clinical 
improvements. 
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SUMMARY 
 
1. Thirty-five children with kanam, diagnosed clinically for the trial in out 
Patient department were observed for clinical diagnosis, laboratory 
diagnosis and treatment of trial medicine. 
  
2. Clinical diagnosis of kanam was done on the basis of clinical features 
described in Balavagadam text. 
 
3. Laboratory diagnosis was done by modern methods of examinations. 
 
4. The various siddha aspects of examination of kanam were carried out and  
 recorded in proforma. 
 
5. The etiology and clinical features of kanam were correlated to primary 
complex. 
 
6. The medicine chosen for clinical treatment and management of kanam was  
 Madhulai Nei internally two times in a day.   
 
7. The observation made during the clinical study showed that the trail drug  
 Madhulai Nei was clinically effective. 
 
8. In Bio chemical analysis, the trial medicine had calcium and ferrous iron, 
which confirmed the clinical prognosis of kanam by Madhulai Nei. 
 
9. Antimicrobial activities of the Madhulai Nei significantly inhibited the 
growth of the bacterial strains against Staphylococcus, Streptococcus, 
Escherichia coli, Pneumococcus, Klebsiella and Proteus which control the 
infection of the kanam. 
 
10. In pharmacological analysis, the trial drug Madhulai Nei had acute  anti-
inflammatory, anti-pyretic, anti-diarrhoeal action, which control the disease 
and confirmed the clinical prognosis of kanam by Madhulai Nei. 
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CONCLUSION 
 
 All the thirty-five out patients of Kanam were treated with Madhulai nei 
internally two times a day. 
 
 No adverse effects were noticed during the treatment period. The 
ingredients of Madhulai Nei are plants origin, easily available and harmless to 
children. The cost is comparatively very low. The medicine has many properties to 
control the signs and symptoms of Kanam. 
  
 
 Clinical results were found to be cured in 69% of cases, Improved cases 
were found in 26% and no changes found in 6% of cases 
 
Because of the encouraging results clinically, the study may be under taken 
with the same drug for prolonged period of time in a large number of cases and it 
may throw new lights for the treatment of kanam. 
 
The trial drug “Madhulai Nei” is denoted in Balavagadam text as a common 
effective drug for all types of kanam and through this trial the effectiveness            
of  Madhulai nei was confirmed and re-established by the author. 
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ANNEXURE-I 
 
PREPARATION AND PROPERTIES OF TRIAL MEDICINE  
 
 
TRIAL MEDICINE 
 
Name of the medicine  : liKjt!ofb<!
Reference    : hizuigml<!)Gpf<jk!lVk<Kul<*!
! ! ! ! ! ! hg<gl<!278!
Okjubie!svg<Ggt<;!(Ingredients) 
!
2* liKjt!s&zs<siX!)436ml*!
3* sQf<kqz<!sIg<gjv!!):1ml*!
4* hSou{<o{b<!)436ml*!
5* sikqg<gib<!
6* sikqh<hk<kqiq!!!!!ujgg<G!29!gqvil<!
7* Wzl<!
!
osb<Ljx!
!
liKjt! s&zs<siX! ,! sQf<kqz<! sIg<gjv! Ngqb! -v{<M! ohiVm<gjtBl<!
l{<sm<cbqz<! Osi<k<K! Gpl<hig<gq<! hSou{<o{b! %m<c! nkqz<! sikqg<gib<, 
sikqh<hk<kqiq,! Wzl<! Ngqb! &e<X! ohiVm<gjtBl<! wMk<K! -tuXh<hig!
uXk<K! ohick<K! Osi<k<K! nMh<Ohx<xqg<! gib<s<sq! hkk<kqz<! uck<K! ogit<t!
Ou{<Ml</!
! ntU!;!gv{<c!ntU (4ml) 
! ! !!gijz!lijz!.!-VOujt!
! fit<!ntU!;!52!fim<gt<!
! NBm<gizl<!;!7!lik!gizl<!
! “uqt<!l{h<hiG!ofb<!-vsibe!
! lqtG!fiz<!OlU!lX!kqr<gt<!
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Nkivl<!;!G{himl<!;!kiK!\Qu!uGh<H!
hk<kqbl<!;!!
-f<ofb<jb!ogiMg<Gl<!gizk<kqz<!HtqjbBl<!Htqh<H!ohiVm<gjtBl<!utq!
Ofijb!uqjtuqg<Gl<!!ohiVm<gjtBl<!gm<miblig!fQg<g!Ou{<Ml</!
kQVl<!Ofib<gt<;!
@ Okiml<,!ubqx<xqjvs<sz<,!gpqs<sz<!-jugTl<!fQr<Gl<!
@ -f<k!ofb<jbs<!sqX!Gpf<jkgTg<Gl<,!ohiqb!Gpf<jkgTg<Gl<!
ogiMg<gzil<!
!
!
liKjt;!(Punica granatum) 
!
OuX!ohbi<gt<;!
! kicll<,!hQsHvl<,!liKtr<gib<,!gPLt<!
!
hpl<,!uqjk;!
! Sju!.!-eqh<H,! ke<jl!.!km<hl<,! hqiqU!.!-eqh<H!
!
osb<jg;!
! ohiK!! ! ! ;! Kui<h<hq,!Gtqi<s<sqB{<mig<gq!
H,!hpk<Okiz<! ! ;! Kui<h<hq,!hsqk<kQk<Ki{<c! ! !
lvh<hm<jm,!Oui<h<hm<jm! ;! HPg<ogiz<zq!! ! ! !
! hpl<! ! ! ! ;! Gtqi<s<sqB{<mig<gq!! !
uqjk!! ! ! ;!! Kui<h<hq,!HPg<ogiz<zq,!sibOlx<xq!!
hpk<kqeiz<! Lh<h{q! Svk<kqz<! gi{<gqe<x! uif<kq,! fQi<! Oui<g<jg,!
-jugt<! Ohil<! $zg! Ofijb! Ohig<Gl<! uib<! fQi<! Dxz<,! uQg<gz,<! lf<kl, <!
ouh<hk<kiz<! d{<mie! gib<s<sz<,! ofR<osiqU,! gikjmh<H,! lbg<gl<! -ju!
Ohil<!OlZl<,!dmz<!Gtqi<s<sq!njmBl<!
hps<six<jx!-jth<H!Ofibqei<g<G!ogiMg<g!lqGf<k!fe<jl!kVl<!
!
sr<jgbxs<!osix<xuqi<g<GR<!se<eqbi!sR<si<k<kq!
br<jgkq!kigljls<!siVOli.!gr<jg!
-Vf<kic!lg<gm<!gqvk<kjzs<osb<!Ofib<Ohil<!
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-Vf<kic!lg<geqgm<!og{<!
uib<fQ'!xz<gsh<H!uif<kquqg<gz<!lf<klqgg<!
gib<ouh<hl<!ofR<osiqU!gikjmh<Hl<!.!Ybi!
lbg<gLf<!kQi<f<KuqMl<!liKtl<!hpk<kiz<!
kbg<glxk<!OkolipqOb!six<X!
!
ouck<KuQp<!hpk<jk!uir<gq!olz<zqb!sQjz!gm<c!
gMg<ogeh<!hqpqf<K!ogi{<M!g{<msi<g<!gjvBr<!%m<c!
Gck<kqm!ouch<H!liXr<!Gtqi<f<kqMl<!nr<g!olz<zil<!
Uck<kkfe<!olipqbq!eiOt!!liKtl<!hpk<kqe<siOx!
! ! ! ! ! )Okve<!G{uigml<*!
! ! ! ! !
Antibacterial activity of Punica granatum in different solvents 
Auteur(s) / Author(s) 
NAIR R. ; CHANDA S. ; 
Antioxidant and Antibacterial Activities of Punica granatum Peel Extracts 
1Authors are with Human Resource Development, Central Food Technological 
Research Inst., Mysore-570 013, India.. 
 
Antibacterial activity of Punica granatum 
 Microbiology Laboratory, Research & Development Centre, Natural Remedies 
Pvt. Ltd., Plot No. 5B, Veerasandra Indl. Area, Hosur Road, 561 229, Bangalore, 
India.  
 Synergic interaction between pomegranate extract and antibiotics against 
Staphylococcus aureus 
 Departamento de Biologia Geral, Instituto de Ciencias Biologicas, Universidade 
Federal de Minas Gerais, Brazil. 
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 Study on wound healing activity of Punica granatum peel 
 Department of Plant Cell Biotechnology, Central Food Technological Research 
Institute, Mysore-570 020, Karnataka, India.  
!
!
sQf<kqz<!
Tinospora cordifolia 
!
OuX!ohbi<gt<;!
! ! ! nlqi<kuz<zq,!Osiluz<zq,!nlqi<jk,!nlqi<kgogic,!
G{<mzq!
hbe<hMl<!dXh<H;!
! ! ! -jz,!ogic,!Oui<)gqpr<G*!
Sju.jgh<H!!ke<jl.ouh<hl<!!hqiqU.gii<h<H!
osb<jg!;!
! ! dmx<Oxx<xq! ! ! . Alternative 
! ! Ljx!ouh<hgx<xq! ! .!Anti periodic 
! ! dt<tpzix<xq!! ! .!Demulcent 
! ! ouh<hL{<mig<gq!! ! .!Stimulent 
! ! hsqk<kQk<Ki{<c! ! - Stomachic 
! ! dvlig<gq!! ! ! . Tonic 
! ! sqXfQi<!ohVg<gq)osix<h*! .!Mild diueritic 
sQf<kqz<!si<g<gjv;!
! ! “nLk!uz<zqg<ogic!bg<giv!L{<cmk<!
! ! kqlqVX!OlgOfib<k<!kQobzi!liXOl” 
! ! ! ! ! )Okve<!ou{<hi*!
!
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“Gm<ml<!hkqoem<Ml<!GR<svk<kqe<!Oxix<osixqBr<!
gm<ml<!ohiqkir<!gbOfiBl<!.!hm<mUme<!
osf<kQLe<!hR<oseOu!sQf<kZh<!Ohimjtf<k!
kf<ki!utfQi<g<Gs<!sil<”!
! ! ! ! !!!!!)Okve<!ou{<hi*!!!
sQf<kqz<!si<g<gjv!osb<Bl<!Ljx;!
fe<xib<!-ck<k!sQf<kqx<!ogicjbg<!Gtqi<f<k!fQiqzqm<M!lX!fit<!gjmf<K!
kqh<hqjbg<! gsg<gqh<! hqpqf<K! fQg<gq! oubqzqz<! -v{<M! nz<zK! &e<X! l{q!
Ofvl<!jug<g! fQi<! oktqBl<.nf<k! fQjv!-Xk<Kuqm<M! OuX!fQi<! uqm<Mg<gzg<gq!
Olx<g{<mhcOb! fQjv! -Xk<Kuqce<! hqe<! ncbqx<! hcf<kqVg<Gl<! liOu!
sQf<kqx<si<g<gjvbil</!-jk!dzik<<kqg<!ogi{<M!uibqzqm!jgh<hqVg<Gl</-jks<!
Svr<gTg<Gh<! hqe<! Wx<hMl<!dmz<! -jth<hqx<Gl<,! l{<{Qvz<! uQg<gl<!nz<zK!
utq! gilijz,! -Vlz<,! &i<s<js,! uif<kq! lx<Xl<! Ogijpg<gm<M!
NgqbjugTg<Gl<!upr<gzil</!
! -K!fim<hm<m!sqXfQi<h<!jhbqe<!kihqkr<gTg<G!lqgs<!sqxf<kK/!
Tinospora cordifolia  
Family: Menispermaceae 
Pharmacological Activities 
Antiallergic Activity 
Anticancer Activity 
Antineoplastic Activity  
Antioxidant Activity 
Antistress Activity 
Antiulcer Activity 
Immunomodulatory Activity  
Hepatoprotective Activity 
Hypoglycaemic Activity 
Chemical constituents including known chemo-types 
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Major constituents  
Sesquiterpene tinocordifolin1, sesquiterpene glucoside tinocordifolioside2, 
tinosponone3, tinocordioside4, cordioside4, furanoid diterpenes6; a new clerodane 
furano-diterpene viz. columbin7, tinosporaside5; an immunologically active 
arabinogalactan8; two phytoecdysones9 viz., ecdysterone and makisterone and 
several glycosides10 isolated as polyacetates . 
 
Others  
Alkaloidsll.12 viz., jatrorrhizine, palmatine, berberine, tembeterine; phenyl 
propene disaccharides cordifolioside A, Band C2.10; choline, tinosporic acid, 
tinosporal, tinosporon, 20-fJ-hydroxyecdysoneI3, palmatosides C and F14, 
cordifolisiqes D and E15, diterpenoid furanolactonesl6 
 
Dosages 
3-6 g of the drug in powder form and 20-30 g of the drug for decoction (Source: 
Indian Herbal Pharmacopoeia studies done on tinospora conrdifolia. 
 
 Efficacy Of Tinospora Cordifolia In Allergic Rhinitis 
Department of Pharmacology, Indira Gandhi Medical College, Nagpur 440018, 
India. 
! ! ! !
!
!
!
!
!
!
!
!
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Wzl<!
Elattaria cardamomum 
!
OuX!ohbi<gt<;! NR<sq,!Ogivr<gl<,!Kc!
Sju!–!gii<h<H!ke<jl!–!ouh<hl<!hqiqU!–!gii<h<H!
osb<jg!;! !  
! ! ouh<hL{<mig<gq!! ! .!Stimulent 
  ngm<Muib<!ngx<xq!!!!!!!.!Carminative 
! ! hsqk<kQk<Ki{<c! ! -  Stomachic 
!
“oki{<jm!uib<gUt<!kiZG!kr<gtqz<!
! ! Okie<Xl<!Ofibkq!sivl<he<!Olgk<kiz<!
d{<jm!Ohiz<wPr<!gm<c!gqiqs<svl<!
! ! dpjz!uif<kq!sqzf<kq!uq]Svl<!
h{<jm!oug<jg!uqkig!Ofib<!gisLl<!
! ! hiPR<!Osilh<!hq{quqf<K!fm<mLl<!
n{<jm!bQjtue<!hqk<kl<!-jug<ogz<zil<!
! ! Nz!lir<glp<!Wz!lVf<kOk…//”!
! ! ! ! ! )Okve<!G{uigml<*!
!
sikqg<gib<!
Myristica fragrans 
!
OuX!ohbi<gt<;!! Gzg<gib<,!\ikqg<gib<!
!
Sju!–!Kui<h<H,!gii<h<H,!!!ke<jl!–!ouh<hl<,!hqiqU!–!gii<h<H!
!
osb<jg;!!
! ! ouh<hL{<mig<gq!! ! !.!Stimulent 
  ngm<Muib<!ngx<xq!!!!!!!.!Carminative 
! ! dvlig<gq!!!!!!!!!!!!!!.!Tonic 
  l{&m<c! ! ! !.!Aromatic 
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G{l<;!
! ! kiK!fm<ml<!Ohkq!sVuisq!bR<sqv!Ofib<!
! ! YKSui!sr<gisl<!dm<gqvg{q!–!OuOki!
! ! czg<gib<!uVl<hq{qOhil<!Wx<xlbz<!hqk<kr<!
! ! Gzg<gi!bVf<Kui<g<Gg<!%X/!
-keiz<! ohVr<gpqs<sz<! uiBuqeiZ{<miGl<! Ofib,<! kjzuzq,!
-jvh<H)Suisl<*,! -Vlz<)gisl<*,! fim<mhm<m! gpqs<sz<,! ouh<hk<jk! Le<eqm<M!
uVl<! hq{qgt<! -jugt<! OhiGl</OlZl<! ubqx<Xuzq! ubqx<Xh<ohiVlz<!
ng<gqeqlf<kl<!-jugjtBl<!Ohig<Gl</!!
!
Following studies done on Myristica fragrans 
Antibacterial principles from Myristica fragrans seeds. 
Department of Pharmaceutical Sciences, Guru Jambheshwar 
University, Hisar, Haryana, India. 
! ! ! ! ! !
sikqhk<kqiq!
          Myristica fragrans 
 
OuX!ohbi<gt<;! \ikqhk<kqiq,!uSuisq!
Sju!–!Kui<h<H!gii<h<H!!!!ke<jl!–!ouh<hl<!hqiqU!–!gii<h<H!
!
osb<jg;!!
! ! ouh<hL{<mig<gq!! ! !.!Stimulent 
  ngm<Muib<!ngx<xq!!!!!!.!Carminative 
! ! dxg<gL{<mig<gq!!!!!!!!.! Hypnotic 
G{l<;!!
! ! sikqkVl<!hk<kqiqg<Gk<!kihs<!Svf<k{qBl<!
! ! YKgqe<x!hqk<kl<!dbVr<gi{<!.!kiKuqi<k<kq!
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BUTTER 
 
Butter, unsalted 
Nutritional value per 100 g 
Energy 720 kcal   3000 kJ 
Carbohydrates     0 g 
Fat 81 g 
- saturated  51 g  
- monounsaturated  21 g    
- polyunsaturated  3 g    
Protein 1 g 
Vitamin A  684 µg 76% 
Cholesterol 215 mg 
 
 
Source: USDA Nutrient database 
!
!
!
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ANNEXURE-II 
 
PHARMACOLOGICAL STUDY 
 
PHARMACOLOGICAL ACTIVITIES OF 
MADHULAI NEI- 
A. SIDDHA DRUG 
 
Anti-inflammatory testing 
 The anti-inflammatory property of Madhulai Nei was investigated using the 
model of carrageenin-induced rat paw edema. Male rats weighing 120-150 g were 
used. A 0.05 ml of 1% freshly prepared suspension of carrageenin in 0.9% saline 
was injected into the plantar side of the right hind paw of unanesthetized rats. 
Reference drug (Aspirin 150mg/kg), Madhulai Nei and control vehicle were given 
orally 30 min before the injection of carrageenin. The volume of the paw was 
measured by means of mercury displacement technique using a plethymometer 
before and 1, 3, 5 h after the carrageenin injection. 
 
Antipyretic activity 
 Antipyretic property of Madhulai Nei was tested in rats in which 
hyperthermia had been induced. Initial rectal temperatures of the rats were 
recorded using a six-channel electric digital telethermometer, connected with 
probes. Rats were made hyperthermic by subcutaneous injection of 20% yeast 
suspension at a dose of 1 ml/100 g body weight. When the temperature was at 
peak (18 h after yeast injection) the rectal temperature were again recorded. Those 
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animals that showed a rise in rectal temperature of more than 1.20C were selected 
for the further study. Test substances and control vehicle were given orally and the 
rectal temperature of animals was recorded at 30 min intervals for 2 h following 
the administration of standard drug or Madhulai Nei. 
 
Antinociceptive testing 
 The antinociceptive property of Madhulai Nei was tested using the model 
of writhing response in mice. Swiss albino mice of either sexes weighing 20-30 g 
were used. The writhing syndrome was elicited by an intraperitoneal injection of 
0.7% acetic acid at the dose of 0.1ml/10 g body weight. Test substances and 
control vehicle were orally administered into the mice 30 min before acetic acid 
and the number of writhes was noted for 25 min beginning 5 min after acetic acid 
injection. 
Drugs 
 The following chemicals were used: Acetylsalicylic acid, Brewer’s yeast, 
Glacial acetic acid and Carrageenin. 
Statistical analysis 
 Student’s t-test was used to determine a significant difference between the 
control group and experimental group. 
 
RESULTS 
Anti-inflammatory activity 
 The results of carrageenin-induced rat paw edema which indicate the anti-
inflammatory activity of Madhulai Nei and standard drug are presented in Table 1. 
Doses used were 400mg/kg of Madhulai Nei and 150 mg/kg of Aspirin. It was 
found that both are significantly inhibited the edema formation induced by 
carrageenin in a dose-related manner when the assessment was made 3 h after 
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carrageenin injection. At the dose of 400 mg/kg, exhibited a comparable inhibitory 
effect on the paw edema as aspirin (150 mg/kg) and it was calculated as 53%.  
 
Antipyretic activity 
 As shown in Table 2, the Madhulai Nei at the dose of 400mg/kg caused a 
significant lowering in rectal temperature of hyperthermic rats. A similar result 
was observed with the paracetamol at dose of 100mg/kg. The decrease in rectal 
temperature still existed when assessment was made 2 h after test drug 
administration and efficacy was comparable to that of paracetamol at a dose of 
100 mg/kg.. 
Antinociceptive activity 
 The effect of Madhulai Nei on the writhing response in mice is shown in 
Table 3. It was found that both Madhulai Nei and Aspirin caused an inhibition on 
the writhing response induced by acetic acid. Doses of 400 and 150 mg/kg of the 
Madhulai Nei and aspirin respectively, could completely block the writhing 
response exhibited about 82.5% inhibition. 
 
DISCUSSION 
 The carrageenin induced rat paw edema is the preliminary screening model 
for searching for potential anti-inflammatory compounds. The edema formation is 
a biphasic event, the early (during the first hour) hyperemia being due to the 
release of histamine and serotonin and the delayed edema to the release of 
bradykinin and prostaglandins. The present study shows that the Madhulai Nei at 
the dose of 400mg/kg did not show any inhibitory effect on the edema formation 
at the first hour after carrageenin injection. A marked inhibition of edema 
formation was observed at the third and fifth hour. The Standard drug at the 
same dose range caused a significant inhibition of the edema formation even at the 
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first hour and the effect still existed at the fifth hour. These results tend to suggest 
that the Madhulai Nei possess an anti-inflammatory activity and that the 
mechanism of action may be associated with the histamine, serotonin, bradykinins 
and prostaglandins. 
 Since antipyretic and antinociceptive activities are commonly mentioned as 
characteristic of drugs or compounds, which have an inhibitory effect on 
prostaglandin-biosynthesis, the yeast-induced hyperthermia in rat model was, 
therefore, employed to investigate the antipyretic activity of Madhulai Nei. Dose 
of the Madhulai Nei in the effective anti-inflammatory dose range was used. It was 
found that Madhulai Nei at the dose of 400 mg/kg showed a significant decrease in 
rectal temperature similar to that of the standard. This result seems to support the 
view that the drug has some influence on prostaglandin biosynthesis because 
prostaglandin is believed to be a regulator of body temperature. 
 The analgesic activity of Madhulai Nei was also evaluated using the 
writhing test in mice. Acetic acid, which is used as an inducer for writhing 
syndrome, causes algesia by liberation of endogenous substances, which then 
excite the pain nerve endings. The Madhulai Nei was found to exert a significant 
inhibitory activity on writhing response in dose range of 400 mg/kg. The results 
obtained rather suggest that Madhulai Nei posses an antinociceptive activity and 
the mode of action might involve a peripheral mechanism. However, the central 
mechanism also might be involved. 
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Table -1. Effect of Madhulai Nei on carrageenin-induced rat paw edema 
Drug Used Time after carrageenin injection 
1 h 3 h 5 h 
EV EI 
(%) 
EV EI (%) EV EI(%)
Control 
 
Aspirin  
150 mg/kg 
 
Madhulai 
Nei  
400 mg/kg 
0.24±0.05 
 
 
0.11±0.06* 
 
 
0.15±0.03* 
- 
 
 
54.2 
 
 
37.5 
0.70±0.17 
 
 
0.34±0.13*
 
 
0.36±0.11*
- 
 
 
51.4 
 
 
48.6 
1.00±0.38 
 
 
0.47±0.10* 
 
 
0.38±0.13* 
- 
 
 
53.0 
 
 
62.0 
Values are expressed as Mean±S.E.M. Drug and test compounds were given orally 
30 min before carrageenin injection. *P<0.05; significantly different from the 
control group (N=6). EV- Edema volume, EI- Edema inhibition 
 
Table –2. Effect of Madhulai Nei on yeast-induced hyperthermia in rats 
Drug Used Rectal temperature (0C) 
 
Initial 
18 h after 
yeast 
injection 
 
 
Time after drug injection (min) 
30 60 120 240 
Control 
ASA  
150 mg/kg 
 
Madhulai nei  
400 mg/kg 
37.1±0.0 
 
 
37.3±0.0 
 
 
37.3±0.0 
38.3±0.1 
 
 
39.1±0.1 
 
 
38.9±0.1 
38.4±0.1 
 
 
38.6±0.1* 
 
 
38.1±0.2* 
38.5±0.1 
 
 
38.1±0.1* 
 
 
37.8±0.1* 
38.5±0.2 
 
 
38.1±0.1* 
 
 
37.5±0.2* 
38.5±0.3 
 
 
37.8±0.1* 
 
 
37.6±0.2* 
Values are as Mean±S.E.M. Drug and test compounds were given orally *P<0.05; 
significantly different from the rectal temperature 18 h after yeast injection (N=6). 
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Table –3. Effect of Madhulai Nei on writhing response in mice 
Experiment Number of writhes  Inhibition (%) 
Control 
Aspirin 150 mg/kg 
Madhulai nei 400 mg/kg 
36.7±4.2 
6.4±2.1* 
11.8±7.1* 
- 
82.5 
67.8 
Values are expressed as Mean±S.E.M. Drug and test compounds were given orally 
30 min before 0.7% acetic acid injection. *P<0.05; significantly different from the 
control group (N=6). 
 
Studies on Anti diarrhoeal activity of Madhulai nei-A 
siddha drug 
INTRODUCTION: 
 The aim of the therapy in diarrhoea is to treat the patient promptly to reduce 
the loss of electrolytes and water. There are several potent antidiarrhoeal drugs in 
the modern system of medicine [1], however on prolonged use they do have some 
adverse effect [2]. For this reason use of siddha formulation have increased as they 
are devoid of any adverse effects. In the present study, anti diarrhoeal activity of 
Madhulai Nei has been studied using model of castor oil induced diarrhoea in 
mice [3]. For comparison purpose Diphenoxylate hydrochloride, a standard drug 
was taken. Fresh Madhulai nei is yellowish, bitter with a typical agreeable aroma. 
MATERIALS AND METHODS: 
Drugs and Chemicals 
 Castor oil was refined pure from Paras chemical industries. Chlorpromazine 
Hcl was purchased from Rhone poulenc (I) Ltd. Charcoal from E. Merck (I) Ltd. 
Atropine Sulphate was from Central drug house (P) Ltd, Diphenoxylate Hcl was 
purchased from Searle (I) Ltd. and solvents from Qualigens fine chemicals. 
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Dose selection 
 The optimum conditions for experiments were decided on the basis of 
initial pilot experiments performed on three mice per treatment. Madhulai Nei was 
administered at upto 4g/kg to an individual mouse in a group. There was no 
mortality due to this treatment. Hence for further studies 400 mg/kg of maximum 
oral dose was employed. 
Experimental animals 
 Swiss albino mice (25 – 30g) of either sex were originally obtained from 
the king institute, Chennai. T.N. India, and have been maintained in the animal 
house at Vel’s college of pharmacy. Chennai. They were housed in polypropylene 
cages under controlled environment. They were given standard pellet diet 
(Saimeera foods (P) Ltd, Bangalore) and water ad libitum. 
Castor oil induced diarrhoea 
 Mice were divided into three groups as shown in table-1 for the treatment. 
Group – I served as control-received vehicle only (2ml of Tween 80). 
Group – II test group animals received 400 mg/kg of Madhulai Nei. 
Group – III standard group animals received Diphenoxylate Hcl. (5 mg / kg) 
After 30 min each of these animals was given 0.1 ml castor oil by oral route. The 
number of defecations per animal was recorded up to 4 h. 
Small intestinal secretion 
 Intestinal secretion was indirectly analyzed by enteropooling assay. Groups 
of overnight fasted mice were treated with 400 mg/kg Madhulai Nei or vehicle 
orally or chlorpromazine (30 mg/kg.,i.p.) 30 min before the oral administration of 
castor oil, 0.2 ml / mouse. These mice were sacrificed 30 min later, and the entire 
small intestine from each animal was weighed and their group average was 
calculated (Table-2). The difference in the weight of small intestine in control and 
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castor oil treated groups was considered as the castor oil induced accumulation of 
intestinal fluid. 
Small intestinal Transit 
 The effect of the Madhulai Nei on small intestinal transit was studied on 
overnight fasted mice, which were divided in different groups. These groups were 
control, test by oral treatment and 5 mg/kg Atropine Sulphate by intramuscularly. 
30 min after the treatment, these mice were given 0.2 ml charcoal meal. (3% 
charcoal in 5% gum acacia) by oral route. All animals were sacrificed after 20 
min, the stomach and intestine removed, and the distance traveled by charcoal 
with reference to total length was calculated to express the percentage of distance 
traveled. 
Statistical analysis 
All results were reported as Mean ± S.E.M. These results were further analysed by 
using Student’s ‘t’ – test to calculate significance of the results. ‘P’ – value less 
than 0.05 were considered significant. 
 
RESULTS: 
Castor oil induced diarrhoea 
 
 The Madhulai Nei exhibited effective inhibition of castor oil induced 
diarrhoea. This effect is significant as compared with control at 400 mg/kg of 
Madhulai Nei and 5 mg / kg Diphenoxylate hydrochloride as shown in table – 1. 
 
Small intestinal secretion 
 The castor oil induced intra luminal accumulation of fluid inhibited 51.44 % 
at a dose of 400 mg / kg extract. The reference drug chlorpromazine at a dose of 
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30mg / kg reduced intestinal secretion by 96.29 % both these values were significant 
as compared with control as shown in table – 2. 
Small intestinal transit 
 The results of the present study revealed that the Madhulai Nei at 400 
mg/kg and Atropine sulphate at 5mg/kg significantly inhibited the gastrointestinal 
transit of Charcoal in mice by 11.70 and 54.03% respectively, as compared with 
control as shown in table–3. 
 
DISCUSSION: 
 In the present investigation, Madhulai Nei has shown anti diarrhoeal 
activity in a castor oil induced model in albino mice. This activity is significant at 
a dose of 400mg / kg and this effect was also substantiated by significant action or 
castor oil induced intra luminal accumulation of fluid by indirect entero pooling 
assay in mice. The experiments conducted on gastro intestinal motility after 
charcoal meal administration have shown a reduction in the propulsive movement 
of small intestine after pre-treatment with Madhulai Nei or atropine. These results 
demonstrate the inhibitory effect of Madhulai Nei on castor oil induced diarrhoea, 
intra luminal fluid accumulation and peristaltic activity in small intestine. 
Prostaglandin contributes to the pathophysiological functions of the gastro 
intestinal tract, and also on the local electrical and mechanical activities of ileal 
circular muscles. Castor oil increases peristaltic activity and produces permeability 
changes in the intestinal mucosal membrane to electrolytes and water. Induction of 
diarrhoea by castor oil is through elevated prostaglandin biosynthesis [3]. From 
these results, it can be concluded that the drug may act through inhibition of 
prostaglandin and reduction in propulsive movement of small intestinal tract. 
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Table-1 
Effect of Madhulai Nei on Castor oil induced diarrhoea in albino mice 
                    Group Number of mice Mean number of 
defecations 
 
I Control 
II Madhulai Nei (400 mg/kg) 
III Diphenoxylate Hcl (5 
mg/kg) 
 
10 
10 
10 
 
12.40±0.48 
6.0±0.37* 
4.8±0.33* 
Values are as mean ± S.E.M. 
*Significant as compared with control P<0.05 
 
Table-2 
Effect of Madhulai Nei on Castor oil stimulated intraluminal fluid 
accumulation in the small intestine of mice gut. 
 
Group 
Weight of small 
intestine 
(mg/20g+S.E.M.) 
Castor oil induced 
intraluminal fluid (mg) 
 
I Control (CMC) 
 
II Castor oil 
 
III Madhulai Nei (400 mg/kg)
 
IV Chlorpromazine (30 
mg/kg) 
 
 
948+9.12 
 
1412+5.93a* 
 
1134±6.32b** 
 
1012±8.28 b ** 
 
------ 
 
486±5.30 
 
   236±3.61** 
 
18±1.03** 
*Significant as compared with control P<0.05 
**Significant as compared with castor oil treated group P<0.05 
a-Compared between control and castor oil treated group 
b-Compared between castor oil and drug treated group
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Table-3 
Effect of Madhulai Nei on gastro intestinal transit in mice  
 
 
Group 
 
 
Number of mice 
used 
Distance traveled by 
charcoal marker as % of 
total length of small 
intestine (Mean ± 
S.E.M.) 
 
 
% Inhibition 
Control 
Madhulai Nei 
(400mg/kg) 
Atropine Sulphate 
(5mg/kg) 
10 
10 
 
10 
92.21±5.25 
81.42±4.62* 
 
42.38±7.32* 
------- 
11.70 
 
54.03 
*Significant as compared with control. P < 0.05. 
 
REFERENCES: 
1. Margaret Cibulskis. (1983) Cathartics and stool softeners, enemas, and anti 
diarrheals. In: Essentials of pharmacology. pp 119-123 
2. Friedi, G. Hengle. (1980) Loperamide overdose managed by naloxone. Lancet.          
1: 1413. 
3. Awouters, F., Niemegeers, C.J.E., Lenaerts, F.M., and Janssen, P.A.J. (1978) 
Delay of castor oil diarrhoea in rats: a new way to evaluate inhibitors of 
prostaglandin biosynthesis. Journal of pharmacy and pharmacology. 30: 41-
45. 
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ANNEXURE -III 
 
Antimicrobial Activity of Madhulai nei against Strains of 
Staphylococcus, Streptococcus, Escherichia coli, 
Pneumococcus, Klebsiella and Proteus 
  
MATERIALS AND METHODS 
Antimicrobial activity: 
 
Microbial strains 
The tested microorganisms were clinical, animal and food isolates with known 
resistance pattern to common practice antimicrobial factors and were provided from 
the Culture Stock Collection of the Department of Microbiology Vel’s college. The 
bacterial species employed were different strains of Staphylococcus, Streptococcus, 
Escherichia coli, Pneumococcus, Klebsiella and Proteus. The isolates were 
biochemically and serologically characterized. The selected species are common 
pathogens involved in a variety of human and animal infections; all 6 species are well 
recognized for resistance to a number of antimicrobials used in the medical and 
veterinary practice, they are safe for the researchers to handle and experiment with, 
their cultures are of low cost and easily maintained and they are supposed to be 
typical representatives of Gram+/Gram– bacteria. Culture media and inoculum The 
strains of S. aureus and E. coli were maintained on trypticase soy agar, while the 
strains of Klebsiella and Proteus were maintained on Sabouraud dextrose agar. The 
microbial inoculum was prepared from 20 mL of overnight stock cultures in tryptone 
broth at 37 °C and Sabouraud broth at 30 °C The concentration of microbial 
inoculums was within the range of 106 cfu/mL determined by viable counts following 
serial dilutions. The Mueller- -Hinton agar (MHA) for the bacterial strains were used 
for the sensitivity tests.  
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Antibiotic resistance of test strains 
The bacterial strains used for the tests were selected based on their resistance 
to antibiotics, because it was thought that it would be essential to experiment with 
strains already exhibiting resistance mechanisms. All isolates of the selected strains 
exhibited resistance to certain antibiotics. The antibiotic susceptibility test of the 
selected strains was determined by the standard well method. S. aureus strains were 
resistant to amoxycillin, cloxacillin, cefuroxime and nalidixic acid; E. coli strains 
were resistant to doxycycline, novobiocin and cloxacillin. 
 
Antimicrobial assay 
The antimicrobial effect of the Madhulai Nei was tested using the agar well 
diffusion method following the well-established method. Overnight bacterial cultures 
were used for surface inoculation of Petri dishes containing 15 mL of MH agar. Each 
Petri dish was spread on with 0.5 mL of strain inocula streaked thoroughly all over the 
surface of the MHA. Subsequently, four equidistant wells, 4 mm in diameter each, 
were punched into the inoculated medium with sterile glass Pasteur pipettes and were 
filled up with 25 µL of drug solution using a precise pipettor (Eppendorf). All plates 
were incubated at 37 °C and inhibition zones were measured after 24 h. Three 
different strains of each species (1 human isolate, 1 animal isolate, 1 food isolate) 
were tested in duplicate sets of plates, which were simultaneously processed for each 
strain. All the experiments were repeated twice, including two controls with plain 
DMSO and sterilized distilled water every time. After incubation the inhibition zones 
were measured to an accuracy of 1 mm and the effect was calculated as a mean of the 
duplicate experiments for each triplicate strain test. 
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RESULTS AND DISCUSSION 
 Antimicrobial activities of the Madhulai Nei significantly inhibited the 
growth of the bacterial strains against Staphylococcus, Streptococcus, Escherichia 
coli, Pneumococcus, Klebsiella and Proteus.  
 
CONCLUSION 
According to the results of the present screening study the Madhulai Nei 
appear to contain compounds responsible for antimicrobial effects against Gram-
positive and Gram-negative bacteria.  
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ANNEXUR-IV 
 
BIO CHEMICAL ANALYSIS IN MADHULAI NEI 
 
Preparation of the extract 
 5gms of choornam is weighed accurately and placed in a 250 ml clean beaker. 
Then 50 ml of distilled water is added and dissolved it well. Then it was boiled well 
for about 10 minutes. Then cooled it filtered in a 100 ml volumetric flask and then it 
was make up to 100 ml with distilled water. This fluid Is taken for analysis. 
Quantitative analysis 
 
Sl.No Experiment observation Inference 
1. 
 
 
 
Test for calcium 
2ml of the above extract is taken 
in a clean test tube to this added 2 
ml of 4% ammonium oxalate 
solution 
A white precipitate 
was  formed 
Presence of 
trace amount 
of calcium 
2. Test for  sulphate 
   2ml of the above extract added 
with 5% barium chloride solution 
No characteristic 
change 
Absence of 
sulphate 
3. Test for chloride 
  The extract is treated with 
ammonium molybdate and 
concentrated nitric acid 
No characteristic 
change 
Absence of 
chloride 
4. Test for phosphate 
  The extract is treated with 
ammonium molypdate and 
concentrate nitric acid. 
No yellow precipitate 
is obtained 
Absence of 
phosphate 
5. Test for unsaturation 
  Pottasium    permanganate 
solution is added to the extract  
No characteristic 
change 
Absence of 
Unsaturation 
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6. Test for Tannic acid 
  The extract is treated with ferric 
chloride 
No blue black 
precipitated formed 
Absence of 
Tannic acid 
7. Test for Iron 
a. Ferric Iron 
The extract is treated with 
ammonium thiocyanate 
solution 
No blood red colour 
is formed 
Absence of 
ferric iron 
 b. Ferrous iron 
To the extract added 
concentrated Nitric acid and 
then ammonium thiocyanate 
solution 
Blood red colour is 
obtained 
Presence of 
Ferrous Iron 
8. Test for starch 
     The extract is treated with 
weak iodine solution 
No Blue colour 
develops 
Absence of 
starch 
9. 
 
 
Test for Amino acid 
     Once or 2 drops of extract is 
placed on a filter paper and dried 
it well.After that 1% Ninhydrin 
is sprayed over the same and 
dried it well. 
No violet colour 
developed 
Absence of 
Amino acid 
10. Test for Reducing sugar 
  5ml of Benedict’s qualitative 
solution is taken in a test tube 
and allowed to boil for 2 mts and 
added 8 to 10 drops of the extract 
and again boil it for 2 mts 
No colour change Absence Of 
Reducing 
Sugar 
11. Test for carbonate 
     The substance is treated with 
concentrated  HCL 
No brisk 
effervescence is 
formed 
Absence of 
carbonate 
12. Test for Albumin 
   The extract is treated with 
Esbach’s reagent 
No yellow precipitate Absence of 
Albumin 
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ANNEXYRE-IV 
 
STASTICAL ANALYSIS 
 
Table no. (1) Results of Stastical Analysis of Objective Parameters  observed before  
and After Treatment of 35 (n) Patients of kanam , National Institute of  Siddha, 
Chennai-47, during 2007. 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 Parameter                 Mean Statistical 
test  
Criterion(t)
Probability(P) 
value 
Statistical 
Significance 
of the 
Difference 
  Before 
Rx 
After 
Rx 
Difference    
1. Hemoglobin 10.497 12.308     1.8 t = 13.0057 < 0.05 Significant 
        
2. ESR -
1/2hr(mm) 
11.057 5.314     5.74 t = 9.2046 < 0.05 Significant 
        
3. ESR -         
1 hr(mm) 
22.457 10.637     11.77 
 
t = 
11.19140 
< 0.05 Significant 
   
 
 
 
 
 
   
4. Eosinophil 8.971 2.971     6.0 t = 10.5355 < 0.05 Significant 
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Table no. (2) Results of Statically Analysis of Subjective Parameters observed before  
and After Treatment of 35 (n) Patients of kanam , National Institute of 
Siddha, Chennai-47, During 2007. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Parameter Percentage present Statistical 
test  
Criterion 
Probability(P) 
value 
Statistical 
Significance 
of the 
Difference 
  Before 
Rx 
After 
Rx 
Difference    
1. Wheezing    Z = 12.87 < 0.05 Significant 
        
2. Loss of 
appetite 
   Z = 12.48 < 0.05 Significant 
        
3. Cough with 
expectoration 
 
 
 
 
 
 
Z = 15.36 < 0.05 Significant 
   
 
 
 
 
 
   
4. Bowel 
movements 
   Z = 18.05 < 0.05 Significant 
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AN OPEN TRIAL  OF MADHULAI NEI FOR  THE TREATMENT OF KANAM  
 
 
FORM I -SELECTION PROFORMA 
 
 
 
1. O.P NO: -------------------------------------------- 2. S.NO:   
                                    
3.  NAME:   -------------------------------------- 4. AGE (yr)           5.GENDER:  M       F 
 
6. FATHER’S OCCUPATION: -------------------------------- 
 
7. POSTAL ADDRESS 
___________________________________________________________________ 
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________ 
 
8. COMPLAINTS AND DURATION 
___________________________________________________________________ 
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________ 
 
9. HISTORY OF PRESENT ILLNESS 
___________________________________________________________________  
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________ 
 
10. PAST HISTORY: 1.NO        2. YES  ___________________________________ 
  
 
11. FAMILY HISTORY: 1.NO        2. YES    ________________________________ 
  
                                                          
 12. IMMUNIZATION HISTORY      
___________________________________________________________________ 
___________________________________________________________________
___________________ 
GENERAL EXAMINATION 
13. Body weight [kg]                     .         
 
14. Height [cm]                                                    
 
15. Body temperature [ºF]                     .  
 
16. Pulse rate /min.                      
 
17. Heart rate / min.   
 
18. Respiratory rate /min.    
     
   
 (1) Yes       (2) No   
19.  Pallor  
20.  Jaundice    
21.  Clubbing  
22.  Cyanosis  
23.  Pedal edema  
24. Lymph adenopathy            
25. Engorged veins                                             
26. Abdominal distension                         
27. Jugular venous pulsation                         
28. Congenital abnormalities                                                                                                  
                                                        
                         
  
 
 
 
 
 
 EXAMINATION OF OTHER SYSTEM 
   
                                           (1) Normal    (2) Abnormal  
29.  CVS      ……………............................ 
30.  CNS                                                            ……………………………… 
 
     CLINICAL EXAMINATION 
 
31. INSPECTION: 1.Thin built           2. Normal              3. Obese  
 
32. PALPATION:   1. Normal              2.Abnormal      ………………………………… 
 
33. PERCUSSION: 1.Normal          2.Hyper resonance       3.Hypo resonance 
 
34. AUSCULTATION: 1.Monophonic  Wheeze           2.Polyphonic Wheeze                        
                                     
           3.Diffuse 
                                              
CLINICAL ASSESMENT 
       
(1)Yes             (2) No  
 
 
35 Cough                                                               
 
36. Cough with expectoration                                      
 
37. Nasal catarrh                                                      
 
38. Stuffy nose                                                            
 
39. Loss of appetite      
 
40. Halitosis 
  
 a. Grunting Sound 
                                  
  1. Nil      2. Mild          3.  Moderate      4. Severe                 
 
b. Breathlessness   
  
41. Wheezing                        
 
 
 
 
 
 
1.Normal      2.Mild       3. Moderate        4.High 
            (98-99˙)      (99-100˙)     (100-103˙)      (103-105˙)     
42. Fever             
      1. Nil      2. Mild          3.  Moderate      4. Severe              
43. Abdominal pain                             
 
44. Scanty  micturitation 
 
45. Thurst 
 
46. Dryness of tongue  
        
                      1. Normal  2.Dysentery  3.Diarrhoea  4. Constipation         
47. Bowel 
         1. Normal             2.  Red             3.  Yellow 
 
48. Colour of eyes 
   
  1. Normal              2.Bulk               3. Emaciated 
 
49. Nutrition   
                                                                           
   1. Normal               2. Flat               3.Barrel 
 
50.Shape of chest     
 
SIDDHA ASPECTS 
51. Nilam 
       1. Kurinji             2. Mullai           3. Marutham         4. Neithal          5. Palai 
52. Kaala iyalbu 
         1. Kaarkaalam         2. Koothirkaalam                3. Munpanikaalam      
        4. Pinpanikaalam         5. IlavenirKaalam          6. Muduvenirkaalam 
53. Yaakkai 
 1. Vatham          2. Vatha pitham   3. Vatha kabam     
         4. Pitham     5.Pitha vatham              6. Pitha kabam    
         7. Kabam          8. Kaba vatham             9. Kaba pitham    
54. Gunam 
 1. Sathuvam  2. Rasatham  3. Thamasam 
 
 
 
 
IYMPORIGAL 
 
          (1) Normal     (2) Affected   
55. Mei                                        ………………………………………….. 
56. Vaai                                              ………………………………………… 
57. Kan                                             …………………………………………… 
58. Mookku                                        ………………………………………… 
59. Sevi                                             …………………………………………… 
 
        KANMENDHIRIUM / KANMAVIDAYAM 
 
 (1) Normal     (2) Affected    
60. Kai                                               …………………………………………... 
61. Kaal                                             …………………………………………... 
62. Vaai                                             ………………………………………….. 
63. Eruvaai                                        ………………………………………….. 
64. Karuvaai                                      ………………………………………….. 
 
                                                          
UYIR THAATHUKKAL 
 
Vaatham  
 
                (1) Normal   (2) Affected 
65. Pranan                                          ………………………………………… 
66. Abanan                                        …………………………………………    
67. Viyanan                                       …………………………………………            
68. Uthanan                                       …………………………………………      
69. Samanan                                      ………………………………………….                     
70. Nagan                                          ………………………………………….    
71. Koorman                                     ………………………………………….  
72. Kirukaran                                    …………………………………………         
73. Devathathan                                …………………………………………     
74. Dhananjeyan                               …………………………………………  
 
 
 
 
 
Pittham  
 
                    (1) Normal   (2) Affected 
75. Analagam                                      …………………………………………         
76. Ranjagam                                   ………………………………………..   
77. Sathagam                                   ………………………………………..      
78. Alosagam                                   …………………………………………             
79. Prasagam                                    ………………………………………… 
 
Kabam 
 
                       (1) Normal   (2) Affected 
80. Avalambagam                            …………………………………………. 
81. Kilethagam                                ………………………………………… 
82. Pothagam                                   ………………………………………….          
83. Tharpagam                                …………………………………………..    
84. Santhigam                                 ………………………………………….. 
 
UDAL THAATHUKKAL 
                     (1) Normal      (2) Affected 
85. Saaram                                       ………………………………………..    
86. Senneer                         …………………………………………. 
87. Oon                                          …………………………………………. 
88. Kozhuppu                                …………………………………………. 
89. Enbu                                       … … …………………………………… 
90. Moolai                                           …………………………………………. 
91. Sukkilam /                                  …………………………………………. 
        Suronitham 
ENVAGAI THERVUGAL 
              (1) Normal   (2) Affected 
92. Sparisam                               ……………………………………………….. 
93. Naa                                           …………………………………………….. 
94. Niram                                           ……………………………………………….. 
95. Mozhi                                       ……………………………………………….. 
96. Vizhi                                          ……………………………………………….. 
 
 
Malam 
             (1) Normal    (2) Affected 
97. Niram                       ………….. …………………………….. 
98. Nurai                          … ………… ………………………….. 
99. Kirumi                            ………………………………………….. 
100. Kalappu                                   …………………………………………. 
101. Thanmai   1. Normal              2. Irugal             3.  Ilagal 
 
Moothiram 
    Neerkuri 
 
          (1) Normal  (2) Affected 
102. Niram                             ………………………………………………….. 
103. Manam                                     ………………………………………………… 
104. Edai                       ………………………………………………… 
105. Nurai                    …………………………………………………. 
106. Enjal                                 …………………………………………………. 
                                                           
107. Neikuri 
1. Vaatham              2. Pittham               3. Kabam         
108. Naadi     
 1. Vatham          2. Vatha pitham   3. Vatha kabam     
         4. Pitham     5.Pitha vatham              6. Pitha kabam    
         7. Kabam          8. Kaba vatham             9. Kaba pitham    
LAB INVESTIGATIONS 
 
BLOOD 
 
109. TC (cells / cu.m.m) 
 
DC (%) 108.L.           109.N             110.M            111.E               112.B 
 
 
110. ESR (mm) ½ Hr              114. ESR (mm) 1 Hr 
 
 
111. Hb (g %)           .   .  
 
 
     
 
 
 
112. RBC count (cells/cu.mm ) 
           
                 MOTION TEST 
 
                                           Nil                    Present 
113.Ova  
  
                                           Nil                    Present 
114.Cyst 
 
 
                                         Negative             Positive 
 
115. Occult Blood 
 
 
116. Admitted to trial  ?           1.Yes    2.No  
 
117. If yes,                S.No:      
 
118. Drugs Issued: Madhulai nei (ml) 
 
   
119. Date……………… 
 
 
120. Station……………………                       121.  Signature of Doctor----------------- 
                                     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
 
 
 
 
 
NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47. 
 
AN OPEN TRIAL OF MADHULAI NEI FOR THE TREATMENT OF KANAM  
 
                                               CONSENT FORM 
 
                                         Certificate by Investigator    
 
 
          I certify that I have disclosed all details about the study in the terms readily 
understood by the patient. 
 
 
Date: ____________                                          Signature: ______________ 
 
                                                                            Name: _________________ 
 
 
                                                    Consent of Patient 
 
          I have been informed to my satisfaction, by the attending physician, the 
purpose of the clinical trial, and the nature of drug treatment and follow-up including 
the laboratory investigations to be performed to monitor and safeguard my body 
functions. 
 
          I am aware of my right to opt out of the trial any time during the course of the 
trial without having to give the reasons for doing so. 
 
         I, exercising my free power of choice, hereby give my consent to be included 
as a subject in the clinical trial of Madhulai Nei for the management of Kanam 
(respiratory tract infections) 
 
Date:  ---------------------------------                    Signature---------------------------------- 
 
                                                                      Name: ------------------------------------ 
 
 
Date:  ---------------------------                          Signature of witness:  -------------------     
                                                                                                               
                                                                      Name:  ---------------------------------------    
                 
                                                                    Relationship: ------------------------------- 
 
 
NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47. 
 
 
AN OPEN TRIAL OF MADHULAI NEI FOR THE TREATMENT OF KANAM  
 
 
FORM II – ASSESMENT PROFORMA 
 
 
1.  O.P. No: ----------------------------------------------------  2.S.No: 
 
3. NAME: ----------------------------------------- 
 
4. DATE OF ADMISSION: 
 
5. DATE OF THIS ASSESSMENT    
 
 
6. DAY OF ASSESSMENT                               
 
CLINICAL ASSESMENT 
      (1)Yes             (2) No  
7.  Cough                                                               
 
8. Cough with expectoration                                      
 
9. Nasal catarrh                                                      
 
10.  Stuffy nose                                                             
 
11. Loss of appetite      
 
12. Halitosis 
      a. Grunting Sound 
                                  
      1. Nil      2. Mild          3.  Moderate      4. Severe         
 
 
13. Breathlessness   
 
14. Wheezing 
                  1.Normal      2.Mild       3. Moderate        4.High 
            (98-99˙)      (99-100˙)     (100-103˙)      (103-105˙)     
15. Fever    
 
      
      
           1. Nil      2. Mild          3.  Moderate      4. Severe         
16. Abdominal pain                             
 
17. Scanty  micturitation 
 
18. Thurst 
 
19. Dryness of tongue  
      
                      1. Normal  2.Dysentery  3.Diarrhoea  4. Constipation      
20. Bowel 
         1. Normal             2.  Red             3.  Yellow 
 
21. Colour of eyes 
   
  1. Normal              2.Bulk               3. Emaciated 
 
22. Nutrition   
                                                                           
   1. Normal               2. Flat               3.Barrel 
 
23.Shape of chest     
 
     
LAB INVESTIGATIONS 
 
BLOOD 
 
24. TC (cells / cu.m.m) 
 
DC (%) 25.L.              26.N             27.M            28.E                   29.B 
 
 
30. ESR (mm) ½ Hr              31. ESR (mm) 1 Hr 
 
 
32. Hb (g %)           . .  . 
 
 
33. RBC count (cells/cu.mm  
           
                 
 
   
     
      
 MOTION TEST 
                                           Nil                    Present 
34.Ova                                                                   ___________ 
  
                                           Nil                    Present 
35.Cyst                                                                   _____________ 
 
                                         Negative             Positive 
 
36. Occult Blood 
 
TESTS IN SIDDHA ASPECTS 
Moothiram 
    Neerkuri 
 
          (1) Normal  (2) Affected 
 37. Niram                              …………………………….. 
 38. Manam                                        …………………………….. 
 39. Edai                          …………………………….. 
 40. Nurai                      …………………………….. 
 41. Enjal                                           …………………………….. 
 42. Neikuri 
1. Vaatham         2. Pittham      3. Kabam         
 43. Naadi     
    1. Vatham          2. Vatha pitham   3. Vatha kabam     
      4. Pitham     5.Pitha vatham              6. Pitha kabam    
      7. Kabam          8. Kaba vatham             9. Kaba pitham    
 
 44. RESULT :  1. Cured            2. Improved          3. No change 
                                                           
 45. Drugs   returned: Madhulai nei  (ml) 
 
 46. Drugs Issued: Madhulai nei  (ml) 
   
 47. Date……………… 
 
 
48. Station……………………                           49.  Signature of Doctor------------ 
                                     
 Tinospora cordifolia        Tinospora cordifolia 
!!!!sQf<kqz<! ! ! ! !!!!!! ! sQf<kqz<!si<g<gjv!
 
         
 
 
               Punica granatum                 Punica granatum 
            liKjt        liKjt    
 
        
 
 
 
       Myristica fragrans                                      Myristica fragrans           
              sikqg<gib<!!!!!!!!!!!!!!!!!!!!!!!!!!!!sikqh<hk<kqiq!!!!! 
       
                           
    
                    Myrtica fragrans           Myrtica fragrans 
              !sikqg<gib<!!!!!!!!!!!!!!!!!!!!!!!!!!!sikqh<hk<kqiq!!!!!!
        
                   
 
        Elettaria cardamomum                                          Elettaria cardamomum                    
            Wzl<! ! ! ! ! ! ! Wziqsq!
        
             
                                                                                       
                 liKjt!ofb<!
                                            
 
!!!!!!!!! 
                                                                                  
